https://www.mesothelioma-line.com/consistent-gene-expression-profiles-in-mextag-transgenic-mouse-and-wild-type-mouse-asbestos-induced-mesothelioma/ 2016-01-05T16:17:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/germline-bap1-mutational-landscape-of-asbestos-exposed-malignant-mesothelioma-patients-with-family-history-of-cancer/ 2016-01-05T16:17:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/outcomes-of-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-for-peritoneal-mesothelioma-experience-of-a-peritoneal-surface-malignancy-center/ 2016-01-11T19:42:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/use-of-anti-noxa-antibody-for-differential-diagnosis-between-epithelioid-mesothelioma-and-reactive-mesothelial-hyperplasia/ 2016-01-11T19:46:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/hmgb1-and-its-hyper-acetylated-isoform-are-sensitive-and-specific-serum-biomarkers-to-detect-asbestos-exposure-and-to-identify-mesothelioma-patients/ 2016-01-11T19:52:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-malignant-mesothelioma-pmm-and-primary-peritoneal-serous-carcinoma-ppsc-and-reactive-mesothelial-hyperplasia-rmh-of-the-peritoneum-immunohistochemical-and-fluorescence-in-situ-hybri/ 2016-01-11T20:05:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/dna-copy-number-gains-in-malignant-pleural-mesothelioma/ 2016-01-11T20:09:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/foreign-body-granuloma-mimicking-recurrence-of-malignant-pleural-mesothelioma/ 2016-01-15T14:11:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/functional-analysis-of-the-adrenomedullin-pathway-in-malignant-pleural-mesothelioma/ 2016-01-15T14:17:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/young-investigator-challenge-microrna-21microrna-126-profiling-as-a-novel-tool-for-the-diagnosis-of-malignant-mesothelioma-in-pleural-effusion-cytology/ 2016-01-15T14:19:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/kat5-tip60-is-a-potential-therapeutic-target-in-malignant-pleural-mesothelioma/ 2016-01-22T14:20:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-clinical-prediction-model-for-prognosis-in-malignant-pleural-mesothelioma-using-decision-tree-analysis/ 2016-01-22T14:23:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-mesothelioma-of-the-tunica-vaginalis/ 2016-01-22T14:26:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/influence-of-aqp1-on-cell-adhesion-migration-and-tumor-sphere-formation-in-malignant-pleural-mesothelioma-is-substratum-and-histological-type-dependent/ 2016-01-22T14:29:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/massive-localized-malignant-pleural-mesothelioma-lmpm-manifestations-on-computed-tomography-in-6-cases/ 2016-01-22T14:33:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/recurrent-benign-multicystic-peritoneal-mesothelioma-approach-to-this-rare-condition/ 2016-01-22T14:36:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/differential-microrna-expression-profiling-of-mesothelioma-and-expression-analysis-of-mir-1-and-mir-214-in-mesothelioma/ 2016-01-29T13:53:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/iron-signature-in-asbestos-induced-malignant-pleural-mesothelioma-a-population-based-autopsy-study/ 2016-01-29T13:57:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/protocol-for-pit-a-phase-iii-trial-of-prophylactic-irradiation-of-tracts-in-patients-with-malignant-pleural-mesothelioma-following-invasive-chest-wall-intervention/ 2016-01-29T14:14:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-and-therapeutic-implications-of-microrna-in-malignant-pleural-mesothelioma/ 2016-01-29T14:17:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/retrospective-analysis-of-unknown-primary-cancers-with-malignant-pleural-effusion-at-initial-diagnosis/ 2016-01-29T14:20:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/cpg-oligodeoxynucleotides-exert-remarkable-antitumor-activity-against-diffuse-malignant-peritoneal-mesothelioma-orthotopic-xenografts/ 2016-01-29T14:25:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/enox2-based-early-detection-oncoblot-of-asbestos-induced-malignant-mesothelioma-4-10-years-in-advance-of-clinical-symptoms/ 2016-01-29T14:29:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-and-respiratory-diseases/ 2016-02-05T15:37:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-malignant-peritoneal-mesothelioma-presenting-with-psammomatous-calcification-on-a-cervical-smear/ 2016-02-05T15:02:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/contemporary-analysis-of-prognostic-factors-in-patients-with-unresectable-malignant-pleural-mesothelioma/ 2016-02-05T15:09:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/carbon-nanotube-and-asbestos-exposures-induce-overlapping-but-distinct-profiles-of-lung-pathology-in-non-swiss-albino-cf-1-mice/ 2016-02-05T15:13:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/antagonizing-the-hedgehog-pathway-with-vismodegib-impairs-malignant-pleural-mesothelioma-growth-in-vivo-by-affecting-stroma/ 2016-02-05T15:18:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/whole-exome-and-targeted-deep-sequencing-identify-genome-wide-allelic-loss-and-frequent-setdb1-mutations-in-malignant-pleural-mesotheliomas/ 2016-02-05T15:23:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-exposure-assessment-in-the-first-case-of-intrasplenic-mesothelioma/ 2016-02-05T15:27:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesotheliomas-with-unknown-exposure-to-asbestos-a-re-examination/ 2016-02-05T15:31:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/health-risk-associated-with-airborne-asbestos/ 2016-02-05T15:38:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/analytical-transmission-electron-microscopy-of-amphibole-fibers-from-the-lungs-of-quebec-miners/ 2016-02-05T15:45:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidence-and-survival-trends-for-malignant-pleural-and-peritoneal-mesothelioma-australia-1982-2009/ 2016-02-05T15:46:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/human-lung-derived-mesenchymal-stem-cell-conditioned-medium-exerts-in-vitro-antitumor-effects-in-malignant-pleural-mesothelioma-cell-lines/ 2016-02-12T13:35:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/radiation-induced-mesothelioma-among-long-term-solid-cancer-survivors-a-longitudinal-analysis-of-seer-database/ 2016-02-12T13:48:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/expected-number-of-asbestos-related-lung-cancers-in-the-netherlands-in-the-next-two-decades-a-comparison-of-methods/ 2016-02-12T13:50:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/genome-wide-analysis-of-abdominal-and-pleural-malignant-mesothelioma-with-dna-arrays-reveals-both-common-and-distinct-regions-of-copy-number-alteration/ 2016-02-12T13:52:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/downregulation-of-thymidylate-synthase-by-rnai-molecules-enhances-the-antitumor-effect-of-pemetrexed-in-an-orthotopic-malignant-mesothelioma-xenograft-mouse-model/ 2016-02-12T13:55:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/contemporary-analysis-of-prognostic-factors-in-patients-with-unresectable-malignant-pleural-mesothelioma-2/ 2016-02-12T13:59:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-proteomics-based-approach-identifies-secreted-protein-acidic-and-rich-in-cysteine-as-a-prognostic-biomarker-in-malignant-pleural-mesothelioma/ 2016-02-19T12:39:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/fluoro-edenite-and-carbon-nanotubes-the-health-impact-of-asbestos-like-fibers/ 2016-02-19T12:43:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/monitoring-and-analysis-of-asbestos-concentration-in-working-environment-of-different-asbestos-producing-technologies-in-a-certain-area/ 2016-02-19T12:45:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-an-update-on-diagnosis-and-treatment-options/ 2016-02-19T12:48:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/role-of-mifcd74-signaling-pathway-in-the-development-of-pleural-mesothelioma/ 2016-02-19T12:49:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-with-superior-vena-cava-obstruction-in-young-female-following-short-latency-of-asbestos-exposure/ 2016-02-19T12:54:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-and-molecular-characterization-of-cell-lines-from-japanese-patients-with-malignant-pleural-mesothelioma/ 2016-02-19T12:56:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/hox-transcription-factors-are-potential-targets-and-markers-in-malignant-mesothelioma/ 2016-02-19T13:00:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesotheliomas-show-higher-hyaluronan-positivity-around-tumor-cells-than-metastatic-pulmonary-adenocarcinomas/ 2016-03-07T17:16:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/asymptomatic-localized-pleural-amyloidosis-mimicking-malignant-pleural-mesothelioma-report-of-a-case/ 2016-03-07T17:19:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/plasma-biomarker-enrichment-of-clinical-prognostic-indices-in-malignant-pleural-mesothelioma/ 2016-03-07T17:22:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-mesothelioma-metastasis-to-the-tongue-comparison-with-8-pleural-mesothelioma-reports-with-tongue-metastases/ 2016-03-07T17:24:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/population-pharmacokinetics-and-exposure-response-relationship-of-amatuximab-an-anti-mesothelin-monoclonal-antibody-in-patients-with-malignant-pleural-mesothelioma-and-its-application-in-dose-select/ 2016-03-07T17:27:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/cutaneous-metastases-from-malignant-mesothelioma-of-the-tunica-vaginalis-testis/ 2016-03-07T17:33:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-and-pathologic-predictors-of-clinical-outcome-of-malignant-pleural-mesothelioma/ 2016-03-07T17:36:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-genomic-analysis-of-malignant-pleural-mesothelioma-identifies-recurrent-mutations-gene-fusions-and-splicing-alterations/ 2016-03-07T17:39:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-secretome-signature-of-malignant-mesothelioma-cell-lines/ 2016-03-07T17:41:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/micrornas-are-differentially-regulated-between-mdm2-positive-and-negative-malignant-pleural-mesothelioma/ 2016-03-07T17:44:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/human-malignant-mesothelioma-is-recapitulated-in-immunocompetent-balbc-mice-injected-with-murine-ab-cells/ 2016-03-11T13:22:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-controversies-in-mesothelioma-mesovats-addresses-the-role-of-surgical-debulking/ 2016-03-11T13:24:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/small-cell-mesothelioma-a-rare-entity-and-diagnostic-pitfall-mimicking-small-cell-lung-carcinoma-on-fine-needle-aspiration/ 2016-03-11T13:26:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/time-trend-in-mesothelioma-and-lung-cancer-risk-in-asbestos-workers-in-italy/ 2016-03-11T13:29:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/increased-risk-of-mesothelioma-and-lung-cancer-among-workers-exposed-to-asbestos-who-could-require-an-anticipated-retirement/ 2016-03-11T13:31:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoreductive-surgery-and-intraperitoneal-chemotherapy-an-evidence-based-review-past-present-and-future/ 2016-03-11T13:34:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnosis-and-management-of-patients-with-malignant-peritoneal-mesothelioma/ 2016-03-11T13:35:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-exposure-and-the-risk-of-sinonasal-cancer/ 2016-03-11T13:39:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/positive-ttf-1-expression-in-malignant-mesothelioma-a-case-report/ 2016-03-11T13:41:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-induces-oxidative-stress-and-activation-of-nrf2-signaling-in-murine-macrophages-chemopreventive-role-of-the-synthetic-lignan-secoisolariciresinol-diglucoside-lgm2605/ 2016-03-11T13:43:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/inflammation-related-il-1%ce%b2il-1r-signaling-promotes-the-development-of-asbestos-induced-malignant-mesothelioma/ 2016-03-11T13:45:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-pilot-study-of-volumetric-modulated-arc-therapy-for-malignant-pleural-mesothelioma/ 2016-04-14T20:31:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-humanized-anti-cd26-monoclonal-antibody-inhibits-cell-growth-of-malignant-mesothelioma-via-retarded-g2m-cell-cycle-transition/ 2016-05-04T18:16:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/characterization-of-preneoplastic-and-neoplastic-rat-mesothelial-cell-lines-the-involvement-of-tets-dnmts-and-5-hydroxymethylcytosine/ 2016-05-04T18:27:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/genome-based-mutational-analysis-by-next-generation-sequencing-in-patients-with-malignant-pleural-and-peritoneal-mesothelioma/ 2016-05-05T13:49:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-socio-legal-and-scientific-controversies-and-unsound-science-in-the-context-of-the-worldwide-asbestos-tragedy-lessons-to-be-learned/ 2016-05-03T18:47:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-proliferative-effects-of-asbestos-exposed-peripheral-blood-mononuclear-cells-on-mesothelial-cells/ 2016-05-05T14:12:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-immunostain-and-cdkn2a-p16-fish-analysis-clinical-applicability-for-the-diagnosis-of-malignant-mesothelioma-in-effusions/ 2016-05-11T20:31:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/pain-in-malignant-pleural-mesothelioma-a-prospective-characterization-study/ 2016-05-05T14:37:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/overexpression-of-micro-ribonucleic-acid-591-inhibits-cell-proliferation-and-invasion-of-malignant-pleural-mesothelioma-cells/ 2016-05-10T18:32:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-randomised-study-comparing-the-effectiveness-of-acupuncture-or-morphine-versus-the-combination-for-the-relief-of-dyspnoea-in-patients-with-advanced-non-small-cell-lung-cancer-and-mesothelioma/ 2016-05-10T18:53:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/but-other-than-mesothelioma-an-estimate-of-the-proportion-of-work-related-cancers-in-quebec/ 2016-05-10T19:10:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/massive-chest-wall-resection-and-reconstruction-for-malignant-disease/ 2016-05-10T19:30:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-production-of-corporate-research-to-manufacture-doubt-about-the-health-hazards-of-products-an-overview-of-the-exponent-bakelite-simulation-study/ 2016-05-10T19:47:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-malignant-mesothelioma-and-synchronous-lung-cancer-a-clinicopathological-study-of-18-cases/ 2016-05-11T14:53:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/fatal-pleural-mesothelioma-in-japan-2003-2008-evaluation-of-computed-tomography-findings/ 2016-05-11T15:04:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/manumycin-a-induces-apoptosis-in-malignant-pleural-mesothelioma-through-regulation-of-sp1-and-activation-of-the-mitochondria-related-apoptotic-pathway/ 2016-05-17T16:16:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidence-and-familial-risk-of-pleural-mesothelioma-in-sweden-a-national-cohort-study/ 2016-05-17T16:37:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-potential-protective-effects-of-polyphenols-in-asbestos-mediated-inflammation-and-carcinogenesis-of-mesothelium/ 2016-05-17T17:00:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-therapy-of-malignant-pleural-mesothelioma/ 2016-05-17T17:27:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-closed-abdomen-hyperthermic-intraperitoneal-chemotherapy-hipec-in-the-palliative-treatment-of-neoplastic-ascites-from-peritoneal-carcinomatosis-report-of-a-single-center-experience/ 2016-05-17T17:44:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/geometric-dose-prediction-model-for-hemithoracic-intensity-modulated-radiation-therapy-in-mesothelioma-patients-with-two-intact-lungs/ 2016-05-17T18:10:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/dual-b-and-t-cell-de-immunization-of-recombinant-immunotoxin-targeting-mesothelin-with-high-cytotoxic-activity/ 2016-05-17T18:25:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-pathological-diagnosis-and-treatment-for-pleural-mesothelioma/ 2016-05-24T13:42:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/ctla-4-in-mesothelioma-patients-tissue-expression-body-fluid-levels-and-possible-relevance-as-a-prognostic-factor/ 2016-05-24T14:09:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-pai-1-limits-tumor-angiogenesis-regardless-of-angiogenic-stimuli-in-malignant-pleural-mesothelioma/ 2016-05-24T14:44:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-development-of-targomirs-a-mirna-mimic-based-treatment-for-patients-with-recurrent-thoracic-cancer/ 2016-05-24T14:42:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-copy-number-alterations-in-33-malignant-peritoneal-mesothelioma-analyzed-by-comparative-genomic-hybridization-array/ 2016-05-24T14:56:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/north-american-multicenter-volumetric-ct-study-for-clinical-staging-of-malignant-pleural-mesothelioma-feasibility-and-logistics-of-setting-up-a-quantitative-imaging-study/ 2016-05-24T15:21:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-tumor-specific-neo-antigen-caused-by-a-frameshift-mutation-in-bap1-is-a-potential-personalized-biomarker-in-malignant-peritoneal-mesothelioma/ 2016-05-24T15:36:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/natural-carcinogenic-fiber-and-pleural-plaques-assessment-in-a-general-population-a-cross-sectional-study/ 2016-05-31T16:19:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/metastatic-malignant-pleural-mesothelioma-masquerading-as-a-case-of-acute-abdomen-secondary-to-small-bowel-perforation/ 2016-05-31T17:32:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-age-on-long-term-outcomes-of-surgery-for-malignant-pleural-mesothelioma/ 2016-05-31T17:45:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-gene-of-the-month/ 2016-05-31T18:04:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/biphasic-effects-of-l-ascorbate-on-the-tumoricidal-activity-of-non-thermal-plasma-against-malignant-mesothelioma-cells/ 2016-05-31T18:21:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-initial-experience-in-integrated-18f-fdg-petmr-imaging/ 2016-05-31T18:34:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/neoadjuvant-intratumoral-immuno-gene-therapy-for-non-small-cell-lung-cancer/ 2016-05-31T18:45:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/risk-of-second-primary-cancers-after-malignant-mesothelioma-and-vice-versa/ 2016-06-07T14:16:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/kca1-1-a-calcium-activated-potassium-channel-subunit-alpha-1-is-targeted-by-mir-17-5p-and-modulates-cell-migration-in-malignant-pleural-mesothelioma/ 2016-06-07T14:33:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-value-of-micrornas-in-asbestos-exposure-and-malignant-mesothelioma-systematic-review-and-qualitative-meta-analysis/ 2016-06-07T14:45:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/pharmacokinetics-and-the-effect-of-heat-on-intraperitoneal-pemetrexed-using-a-murine-model/ 2016-06-07T14:57:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/simple-benchmark-for-mesothelioma-projection-for-great-britain/ 2016-06-07T15:07:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-fgffgfr-autocrine-signaling-in-mesothelioma-with-the-fgf-ligand-trap-fp-1039gsk3052230/ 2016-06-07T15:36:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/different-prognostic-roles-of-tumor-suppressor-gene-bap1-in-cancer-a-systematic-review-with-meta-analysis/ 2016-06-07T15:45:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/moving-immune-checkpoint-blockade-in-thoracic-tumors-beyond-non-small-cell-lung-cancer/ 2016-06-14T14:43:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-activin-a-is-a-novel-prognostic-biomarker-in-malignant-pleural-mesothelioma-a-multi-institutional-study/ 2016-06-14T15:15:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/synergistic-anti-tumor-efficacy-of-immunogenic-adenovirus-oncos-102-ad53-d24-gm-csf-and-standard-of-care-chemotherapy-in-preclinical-mesothelioma-model/ 2016-06-14T15:34:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/effect-of-renal-function-on-pemetrexed-induced-haematotoxicity/ 2016-06-14T16:03:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/antitumor-effect-of-novel-anti-podoplanin-antibody-nz-12-against-malignant-pleural-mesothelioma-in-an-orthotopic-xenograft-model/ 2016-06-14T16:20:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/localized-malignant-pleural-sarcomatoid-mesothelioma-misdiagnosed-as-benign-localized-fibrous-tumor/ 2016-06-14T16:28:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/nanoparticle-based-targeted-gene-therapy-for-lung-cancer/ 2016-06-14T16:38:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/reduction-of-estradiol-in-human-malignant-pleural-mesothelioma-tissues-may-prevent-tumour-growth-as-implied-by-in-in-vivo-and-in-vitro-models/ 2016-06-21T16:08:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-epigenetic-biomarkers-in-lung-malignancies-from-early-diagnosis-to-therapy/ 2016-06-21T17:40:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/role-of-respiratory-triggered-diffusion-weighted-mri-in-the-assessment-of-pleural-disease/ 2016-06-21T17:51:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/applications-of-magnetic-resonance-imaging-of-the-thorax-in-pleural-diseases-a-state-of-the-art-review/ 2016-06-21T18:01:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-genetic-landscape-of-malignant-pleural-mesothelioma-results-from-massively-parallel-sequencing/ 2016-06-21T18:15:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-malignant-biphasic-peritoneal-mesothelioma-with-cystic-areas/ 2016-06-21T18:31:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidence-of-mesothelioma-in-lombardy-italy-exposure-to-asbestos-time-patterns-and-future-projections/ 2016-06-21T18:39:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/comorbidity-postoperative-morbidity-and-survival-in-patients-undergoing-radical-surgery-for-malignant-pleural-mesothelioma/ 2016-06-28T13:40:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-ii-study-of-hemithoracic-intensity-modulated-pleural-radiation-therapy-imprint-as-part-of-lung-sparing-multimodality-therapy-in-patients-with-malignant-pleural-mesothelioma/ 2016-06-28T14:09:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-in-a-motor-vehicle-mechanic-case-report-and-review-of-the-literature/ 2016-06-28T14:16:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/prophylactic-radiotherapy-for-the-prevention-of-procedure-tract-metastases-after-surgical-and-large-bore-pleural-procedures-in-malignant-pleural-mesothelioma-smart-a-multicentre-open-label-phase/ 2016-06-28T14:39:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/nanoparticle-tumor-localization-disruption-of-autophagosomal-trafficking-and-prolonged-drug-delivery-improve-survival-in-peritoneal-mesothelioma/ 2016-06-28T14:47:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/establishment-of-anti-mesothelioma-monoclonal-antibodies/ 2016-06-28T14:58:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/progranulin-and-granulin-like-protein-as-novel-vegf-independent-angiogenic-factors-derived-from-human-mesothelioma-cells/ 2016-06-28T15:12:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/angiogenesis-correlates-with-macrophage-and-mast-cell-infiltration-in-lung-tissue-of-animals-exposed-to-fluoro-edenite-fibers/ 2016-06-30T14:30:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-of-peritoneal-surface-malignancies-with-hyperthermic-intraperitoneal-chemotherapy-current-perspectives/ 2016-06-30T14:50:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/low-merlin-expression-and-high-survivin-labeling-index-are-indicators-for-poor-prognosis-in-patients-with-malignant-pleural-mesothelioma/ 2016-07-06T19:27:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/usefulness-of-aquaporin-1-as-a-prognostic-marker-in-a-prospective-cohort-of-malignant-mesotheliomas/ 2016-07-06T19:40:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-pseudoachalasia-hiding-a-malignant-pleural-mesothelioma/ 2016-07-06T19:49:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/incidence-of-malignant-mesothelioma-in-aboriginal-people-in-western-australia/ 2016-07-06T20:02:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/cancer-mortality-in-a-population-exposed-to-nephrite-processing/ 2016-07-06T20:08:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/multidetector-ct-findings-and-differential-diagnoses-of-malignant-pleural-mesothelioma-and-metastatic-pleural-diseases-in-korea/ 2016-07-12T19:22:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/dasatinib-modulates-sensitivity-to-pemetrexed-in-malignant-pleural-mesothelioma-cell-lines/ 2016-07-12T18:45:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/p2x7-targeting-inhibits-growth-of-human-mesothelioma/ 2016-07-12T19:06:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/protocol-of-the-australasian-malignant-pleural-effusion-2-ample-2-trial-a-multicentre-randomised-study-of-aggressive-versus-symptom-guided-drainage-via-indwelling-pleural-catheters/ 2016-07-12T19:33:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/microrna-gene-expression-signatures-in-long-surviving-malignant-pleural-mesothelioma-patients/ 2016-07-15T14:36:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-of-a-third-generation-bisphosphonate-and-replication-competent-adenoviruses-augments-the-cytotoxicity-on-mesothelioma/ 2016-07-15T14:41:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-effusion-of-patients-with-malignant-mesothelioma-induces-macrophage-mediated-t-cell-suppression/ 2016-07-19T14:42:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-effusions-from-mesothelioma-patients-induce-recruitment-of-monocytes-and-their-differentiation-into-m2-macrophages/ 2016-07-19T15:02:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/nccn-guidelines-insights-malignant-pleural-mesothelioma-version-3-2016/ 2016-07-19T15:12:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-efficacy-of-electron-microscopy-and-pleural-effusion-cytology-for-the-distinction-of-pleural-mesothelioma-and-lung-adenocarcinoma/ 2016-07-19T15:26:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-biphasic-pleural-tumor-with-features-of-an-epithelioid-and-small-cell-mesothelioma-morphologic-and-molecular-findings/ 2016-07-19T15:37:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/c-met-expression-and-met-amplification-in-malignant-pleural-mesothelioma/ 2016-07-19T15:49:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/positive-nuclear-bap1-immunostaining-helps-differentiate-non-small-cell-lung-carcinomas-from-malignant-mesothelioma/ 2016-07-25T20:42:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-of-cisplatin-and-lurbinectedin-as-palliative-chemotherapy-in-progressive-malignant-pleural-mesothelioma-report-of-two-cases/ 2016-07-26T13:22:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-report-of-metastasis-of-malignant-mesothelioma-to-the-retromolar-trigone/ 2016-07-26T13:36:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-histomorphologic-grading-system-that-predicts-overall-survival-in-diffuse-malignant-peritoneal-mesothelioma-with-epithelioid-subtype/ 2016-07-26T13:50:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/silencing-receptor-epha2-enhanced-sensitivity-to-lipoplatin-in-lung-tumor-and-mpm-cells/ 2016-07-26T14:01:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/software-for-apportionment-of-asbestos-related-mesotheliomas/ 2016-07-26T14:09:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/brca1-associated-protein-1-bap1-immunohistochemical-expression-as-a-diagnostic-tool-in-malignant-pleural-mesothelioma-classification-a-large-retrospective-study/ 2016-07-26T14:21:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-with-lacrimal-gland-metastasis/ 2016-07-26T14:27:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-related-diseases-and-biological-index-of-cumulative-dose-in-shipyard-workers-1996-2015/ 2016-08-02T20:05:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-incidence-by-nation-wide-cancer-registry-a-population-based-study/ 2016-08-02T20:11:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-of-malignant-pleural-mesothelioma-part-2-therapeutic-approaches-consensus-of-the-austrian-mesothelioma-interest-group-amig/ 2016-08-04T14:31:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-of-malignant-pleural-mesothelioma-part-3-data-from-the-austrian-mesothelioma-interest-group-amig-database/ 2016-08-04T14:39:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/pathology-reporting-of-malignant-pleural-mesothelioma-first-diagnosis-a-population-based-approach/ 2016-08-04T15:06:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/human-car-t-cells-with-cell-intrinsic-pd-1-checkpoint-blockade-resist-tumor-mediated-inhibition/ 2016-08-04T15:19:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/driving-an-improved-car-for-cancer-immunotherapy/ 2016-08-04T15:23:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/pathology-reporting-of-malignant-pleural-mesothelioma-first-diagnosis-a-population-based-approach-2/ 2016-08-09T13:48:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/recurrent-hydropneumothorax-an-unusual-presentation-for-malignant-pleural-mesothelioma/ 2016-08-09T14:01:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/preventing-recurrence-of-diffuse-malignant-peritoneal-mesothelioma/ 2016-08-09T14:12:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-and-crohn-disease/ 2016-08-09T14:22:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/anthophyllite-asbestos-state-of-the-science-review/ 2016-08-09T14:27:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/common-fluorescence-in-situ-hybridization-applications-in-cytology/ 2016-08-09T14:34:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/standardization-of-incidence-rates-of-mesothelioma-in-the-absence-of-national-standards-sensitivity-analysis-in-a-cohort-formerly-exposed-to-asbestos/ 2016-08-09T14:43:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/medical-thoracoscopy-analysis-on-diagnostic-yield-through-30-years-of-experience/ 2016-08-16T15:24:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/trabectedin-is-active-against-malignant-pleural-mesothelioma-cell-and-xenograft-models-and-synergizes-with-chemotherapy-and-bcl-2-inhibition-in-vitro/ 2016-08-16T15:46:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/calpeptin-prevents-malignant-pleural-mesothelioma-cell-proliferation-via-the-angiopoietin1tie2-system/ 2016-08-16T16:08:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-landscape-of-malignant-mesotheliomas/ 2016-08-16T16:23:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-predictive-value-of-pleural-cea-in-patients-with-pleural-effusions-and-histological-findings-a-prospective-study-and-literature-review/ 2016-08-16T18:01:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/symptom-burden-in-mesothelioma-patients-admitted-to-home-palliative-care/ 2016-08-19T17:57:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/alveolar-filling-growth-pattern-of-sarcomatoid-malignant-pleural-mesothelioma/ 2016-08-23T13:31:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-effusions-are-infiltrated-by-cd3-t-cells-highly-expressing-pd-l1-and-the-pd-l1-tumor-cells-within-these-effusions-are-susceptible-to-adcc-by-the-anti-pd-l1-antibody-avelumab/ 2016-08-23T13:39:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-skip-expression-in-malignant-pleural-mesotheliomas-with-ki-67-proliferation-index-and-prognostic-parameters/ 2016-08-23T13:54:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/o-existing-tuberculosis-and-malignant-mesothelioma-with-multiple-sites-venous-thrombosis-a-case-report/ 2016-08-23T14:00:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/pembrolizumab-associated-minimal-change-disease-in-a-patient-with-malignant-pleural-mesothelioma/ 2016-08-23T14:15:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/symptom-burden-in-mesothelioma-patients-admitted-to-home-palliative-care-2/ 2016-08-23T14:27:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-exposure-and-histological-subtype-of-malignant-mesothelioma/ 2016-08-23T14:40:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-18f-fdg-petct-integrated-imaging-in-distinguishing-malignant-from-benign-pleural-effusion/ 2016-08-26T16:55:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/metformin-and-survival-of-people-with-type-2-diabetes-and-pleural-mesothelioma-a-population-based-retrospective-cohort-study/ 2016-08-30T14:10:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/low-homozygoushigh-heterozygous-deletion-status-by-p16-fish-correlates-with-a-better-prognostic-group-than-high-homozygous-deletion-status-in-malignant-pleural-mesothelioma/ 2016-08-30T14:29:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-fluid-from-mesothelioma-has-potent-biological-activities/ 2016-08-30T14:46:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/kdm6b-histone-demethylase-is-an-epigenetic-regulator-of-estrogen-receptor-%ce%b2-expression-in-human-pleural-mesothelioma/ 2016-08-30T14:52:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/arginine-deprivation-with-pegylated-arginine-deiminase-in-patients-with-argininosuccinate-synthetase-1-deficient-malignant-pleural-mesothelioma-a-randomized-clinical-trial/ 2016-09-02T14:17:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/semi-rigid-thoracoscopic-punch-biopsy-using-a-hybrid-knife-with-a-high-pressure-water-jet-for-the-diagnosis-of-pleural-effusions/ 2016-09-02T14:32:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/quercetin-and-cisplatin-combined-treatment-altered-cell-cycle-and-mitogen-activated-protein-kinase-expressions-in-malignant-mesotelioma-cells/ 2016-09-02T14:41:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-of-onconase-and-dihydroartemisinin-synergistically-suppresses-growth-and-angiogenesis-of-non-small-cell-lung-carcinoma-and-malignant-mesothelioma/ 2016-09-06T18:40:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/cd24-is-highly-useful-in-differentiating-high-grade-serous-carcinoma-from-benign-and-malignant-mesothelial-cells/ 2016-09-06T18:48:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-of-the-pleura-with-desmoplastic-histology-a-case-series-and-literature-review/ 2016-09-08T14:20:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/utility-and-pitfall-of-immunohistochemistry-in-the-differential-diagnosis-between-epithelioid-mesothelioma-and-poorly-differentiated-lung-squamous-cell-carcinoma/ 2016-09-08T14:37:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/how-does-the-timing-of-chemotherapy-affect-outcome-following-radical-surgery-for-malignant-pleural-mesothelioma/ 2016-09-08T14:36:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-multicenter-study-of-volumetric-computed-tomography-for-staging-malignant-pleural-mesothelioma/ 2016-09-08T14:46:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/illumination-profile-characterization-of-a-light-device-for-the-dosimetry-of-intra-pleural-photodynamic-therapy-for-mesothelioma/ 2016-09-08T14:55:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-immunohistochemistry-and-p16-fish-results-in-combination-provide-higher-confidence-in-malignant-pleural-mesothelioma-diagnosis-roc-analysis-of-the-two-tests/ 2016-09-13T13:43:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/symptoms-signs-and-radiologic-findings-in-patients-having-reoperative-surgery-for-malignant-peritoneal-mesothelioma/ 2016-09-13T14:02:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/what-is-the-role-of-a-specialist-regional-mesothelioma-multidisciplinary-team-meeting-a-service-evaluation-of-one-tertiary-referral-centre-in-the-uk/ 2016-09-13T14:14:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-irregularities-and-mediastinal-pleural-involvement-in-early-stages-of-malignant-pleural-mesothelioma-and-benign-asbestos-pleural-effusion/ 2016-09-13T15:33:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/pi3-kinase-pathway-and-met-inhibition-is-efficacious-in-malignant-pleural-mesothelioma/ 2016-09-19T18:38:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/validation-of-eortc-and-calgb-prognostic-models-in-surgical-patients-submitted-to-diagnostic-palliative-or-curative-surgery-for-malignant-pleural-mesothelioma/ 2016-09-19T18:59:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-of-malignant-pleural-mesothelioma-part-1-epidemiology-diagnosis-and-staging-consensus-of-the-austrian-mesothelioma-interest-group-amig/ 2016-09-19T19:11:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/promising-in-vivo-efficacy-of-the-bet-bromodomain-inhibitor-otx015mk-8628-in-malignant-pleural-mesothelioma-xenografts/ 2016-09-19T19:20:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/intensity-modulated-radiotherapy-for-relapsed-malignant-pleural-mesothelioma/ 2016-09-22T16:23:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-nlrp3-inflammasome-in-pathogenic-particle-and-fibre-associated-lung-inflammation-and-diseases/ 2016-09-22T16:36:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-mesothelin-osteopontin-and-vimentin-useful-markers-for-clinical-monitoring-of-malignant-pleural-mesothelioma/ 2016-09-23T15:29:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesotheliomas-in-lebanon-witnessing-a-change-in-epidemiology/ 2016-09-23T15:39:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/detection-of-malignant-pleural-mesothelioma-in-exhaled-breath-by-multicapillary-columnion-mobility-spectrometry-mccims/ 2016-09-27T17:58:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/biphasic-malignant-pleural-mesothelioma-masquerading-as-a-primary-skeletal-tumor/ 2016-09-27T18:06:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-iaslc-mesothelioma-staging-project-improving-staging-of-a-rare-disease-through-international-participation/ 2016-09-29T16:52:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-for-malignant-mesothelioma-reality-check/ 2016-09-29T18:33:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-encapsulating-peritoneal-sclerosis-complicated-by-malignant-peritoneal-mesothelioma/ 2016-09-30T13:34:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/symptoms-signs-and-radiologic-findings-in-patients-having-reoperative-surgery-for-malignant-peritoneal-mesothelioma-2/ 2016-09-30T13:51:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/patient-derived-xenograft-establishment-from-human-malignant-pleural-mesothelioma/ 2016-09-30T14:03:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-iaslc-mesothelioma-staging-project-proposals-for-revisions-of-the-n-descriptors-in-the-forthcoming-eighth-edition-of-the-tnm-classification-for-pleural-mesothelioma/ 2016-10-04T16:14:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-iaslc-mesothelioma-staging-project-proposals-for-revisions-of-the-t-descriptors-in-the-forthcoming-eighth-edition-of-the-tnm-classification-for-pleural-mesothelioma/ 2016-10-04T16:23:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-iaslc-mesothelioma-staging-project-proposals-for-the-m-descriptors-and-for-revision-of-the-tnm-stage-groupings-in-the-forthcoming-eighth-edition-of-the-tnm-classification-for-mesothelioma/ 2016-10-04T17:54:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelioid-peritoneal-mesothelioma-a-hybrid-phenotype-within-a-mesenchymal-epithelialepithelial-mesenchymal-transition-framework/ 2016-10-06T17:44:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/rare-presentation-of-a-localised-malignant-pleural-mesothelioma-with-cranial-metastasis/ 2016-10-06T17:54:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/screening-of-pleural-mesotheliomas-for-dna-damage-repair-players-by-digital-gene-expression-analysis-can-enhance-clinical-management-of-patients-receiving-platin-based-chemotherapy/ 2016-10-06T18:08:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-the-vasculature-anti-angiogenic-agents-for-malignant-mesothelioma/ 2016-10-06T18:15:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/circulating-micrornas-found-dysregulated-in-ex-exposed-asbestos-workers-and-pleural-mesothelioma-patients-as-potential-new-biomarkers/ 2016-10-11T19:56:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/pulmonary-tumor-diagnosed-as-an-undifferentiated-sarcoma-with-epithelioid-features-a-case-report/ 2016-10-11T20:05:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/glycodelin-is-a-potential-novel-follow-up-biomarker-for-malignant-pleural-mesothelioma/ 2016-10-11T20:13:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/tyler-asbestos-workers-a-mortality-update-in-a-cohort-exposed-to-amosite/ 2016-10-11T20:19:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/microrna-302b-targets-mcl-1-and-inhibits-cell-proliferation-and-induces-apoptosis-in-malignant-pleural-mesothelioma-cells/ 2016-10-14T19:12:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/optimal-gross-tumor-volume-definition-in-lung-sparing-intensity-modulated-radiotherapy-for-pleural-mesothelioma-an-in-silico-study/ 2016-10-14T19:20:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/systemically-administered-rnai-molecule-sensitizes-malignant-pleural-mesothelioma-cells-to-pemetrexed-therapy/ 2016-10-17T15:40:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/cisplatin-and-resveratrol-induce-apoptosis-and-autophagy-following-oxidative-stress-in-malignant-mesothelioma-cells/ 2016-10-18T15:23:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-cd90-in-the-differential-diagnosis-of-pleural-malignant-mesothelioma-pulmonary-carcinoma-and-comparison-with-calretinin/ 2016-10-21T19:19:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/preclinical-efficacy-of-an-antibody-drug-conjugate-targeting-mesothelin-correlates-with-quantitative-89zr-immunopet/ 2016-10-21T19:27:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-exposure-and-histological-subtype-of-malignant-mesothelioma-2/ 2016-10-21T19:33:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/amount-of-epithelioid-differentiation-is-a-predictor-of-survival-in-malignant-pleural-mesothelioma/ 2016-10-24T15:13:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/polyanionic-biopolymers-for-the-delivery-of-ptii-cationic-antiproliferative-complexes/ 2016-10-25T14:39:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-immunohistochemistry-has-limited-prognostic-utility-as-a-complement-of-cdkn2a-p16-fluorescence-in-situ-hybridization-in-malignant-pleural-mesothelioma/ 2016-10-25T14:49:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-effusions-are-infiltrated-by-cd3-t-cells-highly-expressing-pd-l1-and-the-pd-l1-tumor-cells-within-these-effusions-are-susceptible-to-adcc-by-the-anti-pd-l1-antibody-avelumab-2/ 2016-10-25T15:02:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/vegf-promoter-based-conditionally-replicative-adenoviruses-effectively-suppress-growth-of-malignant-pleural-mesothelioma/ 2016-10-27T13:48:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ii-study-of-pf-03446962-in-patients-with-advanced-malignant-pleural-mesothelioma-cctg-trial-ind-207/ 2016-10-27T14:13:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/myxoid-variant-epithelioid-pleural-mesothelioma-defines-a-favourable-prognosis-group-an-analysis-of-191-patients-with-pleural-malignant-mesothelioma/ 2016-11-01T14:53:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/imaging-in-pleural-mesothelioma-a-review-of-the-13th-international-conference-of-the-international-mesothelioma-interest-group/ 2016-11-01T15:00:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/tamoxifen-suppresses-the-growth-of-malignant-pleural-mesothelioma-cells/ 2016-11-01T15:09:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/statin-suppresses-hippo-pathway-inactivated-malignant-mesothelioma-cells-and-blocks-the-yapcd44-growth-stimulatory-axis/ 2016-11-01T15:18:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/sarcomatoid-type-primary-pericardial-mesothelioma-with-a-long-term-survival-after-the-onset-of-cardiac-tamponade/ 2016-11-04T13:27:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/in-vitro-and-in-vivo-antitumor-activity-of-ptoo-acac%ce%b3-acacdms-in-malignant-pleural-mesothelioma/ 2016-11-04T13:43:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/genomic-profiling-of-malignant-peritoneal-mesothelioma-reveals-recurrent-alterations-in-epigenetic-regulatory-genes-bap1-setd2-and-ddx3x/ 2016-11-07T19:41:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/geographic-distribution-of-incidence-of-pericardial-and-paratesticular-mesotheliomas-in-the-usa/ 2016-11-08T14:34:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/historical-state-of-knowledge-of-the-health-risks-of-asbestos-posed-to-seamen-on-merchant-ships/ 2016-11-11T20:01:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/extended-pleurectomy-decortication-based-treatment-for-advanced-stage-epithelial-mesothelioma-yielding-a-median-survival-of-nearly-three-years/ 2016-11-11T20:11:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-resistance-related-to-targeted-therapy-in-malignant-pleural-mesothelioma-why-has-not-the-target-been-hit-yet/ 2016-11-11T20:19:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-in-the-united-states-a-surveillance-epidemiology-and-end-results-seer-medicare-investigation-of-treatment-patterns-and-overall-survival/ 2016-11-11T20:31:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/residual-fibre-lung-burden-among-patients-with-pleural-mesothelioma-who-have-been-occupationally-exposed-to-asbestos/ 2016-11-11T20:36:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/3d-mass-spectrometry-imaging-reveals-a-very-heterogeneous-drug-distribution-in-tumors/ 2016-11-15T15:29:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/sororin-and-plk1-as-potential-therapeutic-targets-in-malignant-pleural-mesothelioma/ 2016-11-15T14:57:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-and-mesothelial-hyperplasia-a-new-molecular-tool-for-the-differential-diagnosis/ 2016-11-15T15:28:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/intrapleural-adenoviral-mediated-endothelial-cell-protein-c-receptor-gene-transfer-suppresses-the-progression-of-malignant-pleural-mesothelioma-in-a-mouse-model/ 2016-11-15T15:39:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-solitary-well-differentiated-papillary-mesothelioma-with-invasive-foci-in-the-pleura/ 2016-11-29T19:11:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-and-prognostic-biomarkers-in-the-rational-assessment-of-mesothelioma-diaphragm-study-protocol-of-a-prospective-multicentre-observational-study/ 2016-11-29T19:34:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/elevated-aspartate-aminotransferase-and-monocyte-counts-predict-unfavorable-prognosis-in-patients-with-malignant-pleural-mesothelioma/ 2016-11-29T19:44:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-utility-of-pleural-fluid-cell-block-versus-pleural-biopsy-collected-by-flex-rigid-pleuroscopy-for-malignant-pleural-disease-a-single-center-retrospective-analysis/ 2016-11-29T19:56:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/accelerated-cell-cycle-progression-of-human-regulatory-t-cell-like-cell-line-caused-by-continuous-exposure-to-asbestos-fibers/ 2016-11-29T20:06:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/occupation-and-mesothelioma-in-sweden-updated-incidence-in-men-and-women-in-the-27-years-after-the-asbestos-ban/ 2016-11-29T20:13:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/trametinib-plus-4-methylumbelliferone-exhibits-antitumor-effects-by-erk-blockade-and-cd44-downregulation-and-affects-pd1-and-pd-l1-in-malignant-pleural-mesothelioma/ 2016-11-29T20:24:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/fluoro-edenite-induces-fibulin-3-overexpression-in-non-malignant-human-mesothelial-cells/ 2016-12-06T19:51:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-an-update-on-investigation-diagnosis-and-treatment/ 2016-12-06T20:21:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-specific-inhibitor-of-lactate-dehydrogenase-overcame-the-resistance-toward-gemcitabine-in-hypoxic-mesothelioma-cells-and-modulated-the-expression-of-the-human-equilibrative-transporter-1/ 2016-12-06T20:39:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/giant-primary-malignant-mesothelioma-of-the-liver-a-case-report/ 2016-12-06T20:53:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/extrapleural-pneumonectomy-for-malignant-pleural-mesothelioma-a-novel-mini-invasive-technique/ 2016-12-09T18:38:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-comparison-of-singlet-oxygen-explicit-dosimetry-soed-and-singlet-oxygen-luminescence-dosimetry-sold-for-photofrin-mediated-photodynamic-therapy/ 2016-12-09T18:52:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/chest-wall-resection-for-mesothelioma-recurrence-after-surgery-2/ 2016-12-13T14:29:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-evolution-of-the-diminishing-role-of-extrapleural-pneumonectomy-in-the-surgical-management-of-malignant-pleural-mesothelioma/ 2016-12-13T14:41:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/anthophyllite-asbestos-state-of-the-science-review-2/ 2016-12-13T14:56:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/promising-in-vivo-efficacy-of-the-bet-bromodomain-inhibitor-otx015mk-8628-in-malignant-pleural-mesothelioma-xenografts-2/ 2016-12-13T15:16:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/tunneling-nanotubes-an-alternate-route-for-propagation-of-the-bystander-effect-following-oncolytic-viral-infection/ 2016-12-13T15:38:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-with-lacrimal-gland-metastasis-2/ 2016-12-13T15:45:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-surgical-intervention-in-lung-cancer-with-carcinomatous-pleuritis/ 2016-12-16T20:06:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/open-access-phone-triage-for-veterans-with-suspected-malignant-pleural-mesothelioma/ 2016-12-20T16:00:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/signal-transducer-and-activator-of-transcription-1-stat1-knock-down-induces-apoptosis-in-malignant-pleural-mesothelioma/ 2016-12-20T16:28:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/percutaneous-cryoablation-for-the-treatment-of-recurrent-malignant-pleural-mesothelioma-safety-early-term-efficacy-and-predictors-of-local-recurrence/ 2016-12-20T16:43:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/mentored-experience-of-establishing-a-national-peritoneal-malignancy-programme-experience-of-first-50-operative-cases/ 2016-12-20T17:01:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/metachronous-uterine-endometrioid-adenocarcinoma-and-peritoneal-mesothelioma-in-lynch-syndrome-a-case-report/ 2016-12-20T17:12:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-first-case-of-benign-multicystic-mesothelioma-presenting-as-a-splenic-mass/ 2016-12-20T17:22:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-is-altered-by-copy-number-loss-mutation-andor-loss-of-protein-expression-in-more-than-70-malignant-peritoneal-mesotheliomas/ 2017-01-04T17:16:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-importance-of-ezh2-and-moc-31-expression-in-the-differential-diagnosis-of-benign-and-malignant-effusions/ 2017-01-04T17:47:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/computer-aided-volumetric-assessment-of-malignant-pleural-mesothelioma-on-ct-using-a-random-walk-based-method/ 2017-01-04T18:01:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/deciduoid-mesothelioma-of-the-thorax-a-comprehensive-review-of-the-scientific-literature/ 2017-01-04T18:19:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-fluid-from-mesothelioma-has-potent-biological-activities-2/ 2017-01-04T18:26:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/arginine-deprivation-with-pegylated-arginine-deiminase-in-patients-with-argininosuccinate-synthetase-1-deficient-malignant-pleural-mesothelioma-a-randomized-clinical-trial-2/ 2017-01-04T18:36:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-value-of-pretreatment-volume-based-quantitative-18f-fdg-petct-parameters-in-patients-with-malignant-pleural-mesothelioma/ 2017-01-04T18:43:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-fibres-detected-by-scanning-electron-microscopy-in-the-gallbladder-of-patients-with-malignant-pleural-mesothelioma-mpm/ 2017-01-10T15:21:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/usefulness-of-p16cdkn2a-fluorescence-in-situ-hybridization-and-bap1-immunohistochemistry-for-the-diagnosis-of-biphasic-mesothelioma/ 2017-01-12T20:49:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/turning-back-the-wheel-inducing-mesenchymal-to-epithelial-transition-via-wilms-tumor-1-knockdown-in-human-mesothelioma-cell-lines-to-influence-proliferation-invasiveness-and-chemotaxis/ 2017-01-12T21:07:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/role-of-postoperative-radiotherapy-in-the-management-of-malignant-pleural-mesothelioma-a-propensity-score-matching-of-the-seer-database/ 2017-01-12T21:22:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-therapeutic-strategies-for-malignant-pleural-mesothelioma/ 2017-01-12T21:42:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/metabolic-response-assessment-with-18f-fdg-petct-is-superior-to-modified-recist-for-the-evaluation-of-response-to-platinum-based-doublet-chemotherapy-in-malignant-pleural-mesothelioma/ 2017-01-12T21:54:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/blockage-of-epithelial-to-mesenchymal-transition-and-upregulation-of-let-7b-are-critically-involved-in-ursolic-acid-induced-apoptosis-in-malignant-mesothelioma-cell/ 2017-01-17T14:20:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/flex-rigid-pleuroscopic-biopsy-with-the-sb-knife-jr-is-a-novel-technique-for-diagnosis-of-malignant-or-benign-fibrothorax/ 2017-01-17T14:32:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-and-interferon-%ce%b3-dependent-chemokine-ip-10/ 2017-01-17T15:30:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/validation-of-a-gene-expression-test-for-mesothelioma-prognosis-in-formalin-fixed-paraffin-embedded-tissues/ 2017-01-17T15:49:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-and-prognostic-utilities-of-humoral-fibulin-3-in-malignant-pleural-mesothelioma-evidence-from-a-meta-analysis/ 2017-01-20T16:40:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-fluid-cytology-samples-in-cases-of-suspected-lung-cancer-an-experience-from-a-tertiary-care-centre/ 2017-01-24T19:27:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/small-bowel-metastasis-from-pancreatic-cancer-in-a-long-term-survival-patient-with-synchronous-advanced-malignant-pleural-mesothelioma-a-case-report-and-literature-review/ 2017-01-24T19:40:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-deciduoid-mesothelioma/ 2017-01-24T19:53:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/muc4-a-novel-immunohistochemical-marker-identified-by-gene-expression-profiling-differentiates-pleural-sarcomatoid-mesothelioma-from-lung-sarcomatoid-carcinoma/ 2017-01-31T21:44:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-with-excessive-inflammation-and-high-level-of-interleukin-6-a-case-report/ 2017-01-31T21:52:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pericardial-mesothelioma-a-systematic-review-of-current-practice/ 2017-01-31T21:56:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-single-institution-experience-in-percutaneous-image-guided-biopsy-of-malignant-pleural-mesothelioma/ 2017-02-02T19:44:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/geographic-and-socioeconomic-factors-in-patients-with-malignant-pleural-mesothelioma-in-new-south-wales-and-their-impact-upon-clinical-outcomes/ 2017-02-02T19:55:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-mir-21-5p-as-a-functional-regulator-of-mesothelin-expression-using-microrna-capture-affinity-coupled-with-next-generation-sequencing/ 2017-02-02T20:04:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/chest-ultrasonography-in-health-surveillance-of-asbestos-related-lung-diseases/ 2017-02-07T19:41:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/paclitaxel-releasing-mesenchymal-stromal-cells-inhibit-in-vitro-proliferation-of-human-mesothelioma-cells/ 2017-02-08T21:12:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/podoplanin-promotes-progression-of-malignant-pleural-mesothelioma-by-regulating-motility-and-focus-formation/ 2017-02-10T18:02:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostication-and-monitoring-of-mesothelioma-using-biomarkers-a-systematic-review/ 2017-02-10T19:05:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/tissue-transglutaminase-tg2-enables-survival-of-human-malignant-pleural-mesothelioma-cells-in-hypoxia/ 2017-02-10T19:10:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-regional-chemotherapy-for-patients-with-epithelial-malignant-peritoneal-mesothelioma-results-in-improved-survival/ 2017-02-14T16:24:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/3-2-deoxy-%ce%b2-d-erythro-pentafuranosylpyrimido12-%ce%b1purin-103h-one-deoxyguanosine-adducts-of-workers-exposed-to-asbestos-fibers/ 2017-02-14T16:39:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/validation-of-progression-free-survival-as-a-surrogate-endpoint-for-overall-survival-in-malignant-mesothelioma-analysis-of-cancer-and-leukemia-group-b-and-north-central-cancer-treatment-group-allian/ 2017-02-14T16:56:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/hmgb1-targeting-by-ethyl-pyruvate-suppresses-malignant-phenotype-of-human-mesothelioma/ 2017-02-14T17:06:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/large-primary-pleural-synovial-sarcoma-with-severe-dyspnea-a-case-report/ 2017-02-17T15:44:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/does-selective-pleural-irradiation-of-malignant-pleural-mesothelioma-allow-radiation-dose-escalation-a-planning-study/ 2017-02-17T16:12:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/kdm6a-and-kdm6b-altered-expression-in-malignant-pleural-mesothelioma/ 2017-02-17T16:21:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-outcomes-and-prognostic-factors-of-patients-with-advanced-mesothelioma-treated-in-a-phase-i-clinical-trials-unit/ 2017-02-21T14:10:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunohistochemical-detection-of-mtap-and-bap1-protein-loss-for-mesothelioma-diagnosis-comparison-with-9p21-fish-and-bap1-immunohistochemistry/ 2017-02-21T14:26:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/pharmacokinetic-evaluation-of-intrapleural-perfusion-with-hyperthermic-chemotherapy-using-cisplatin-in-patients-with-malignant-pleural-effusion/ 2017-02-21T14:34:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ii-trial-of-dovitinib-in-previously-treated-advanced-pleural-mesothelioma-the-ontario-clinical-oncology-group/ 2017-02-21T14:45:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-renape-observational-registry-rationale-and-framework-of-the-rare-peritoneal-tumors-french-patient-registry/ 2017-02-21T14:58:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/intracavitary-t4-immunotherapy-of-malignant-mesothelioma-using-pan-erbb-re-targeted-car-t-cells/ 2017-02-23T14:13:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/reduced-cell-viability-and-apoptosis-induction-in-human-thyroid-carcinoma-and-mesothelioma-cells-exposed-to-cidofovir/ 2017-02-23T14:32:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/life-expectancy-in-pleural-and-peritoneal-mesothelioma/ 2017-02-28T20:50:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/radiation-therapy-for-malignant-pleural-mesothelioma/ 2017-02-28T20:57:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/aberrant-cytokeratin-20-reactivity-in-epithelioid-malignant-mesothelioma-a-case-report/ 2017-03-02T20:24:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/positive-pleural-cytology-is-an-indicator-for-visceral-pleural-invasion-in-metastatic-pleural-effusions/ 2017-03-02T20:38:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-due-to-asbestos-exposure-in-dental-tape/ 2017-03-02T20:43:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/anti-ctla-4-therapy-for-malignant-mesothelioma/ 2017-03-03T18:50:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-immune-microenvironment-genome-wide-copy-number-aberrations-and-survival-in-mesothelioma/ 2017-03-06T15:30:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/real-time-light-dosimetry-for-intra-cavity-photodynamic-therapy-application-for-pleural-mesothelioma-treatment/ 2017-03-06T15:38:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-mesothelin-osteopontin-and-vimentin-useful-markers-for-clinical-monitoring-of-malignant-pleural-mesothelioma-2/ 2017-03-07T16:38:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/extended-pleurectomy-decortication-based-treatment-for-advanced-stage-epithelial-mesothelioma-yielding-a-median-survival-of-nearly-three-years-2/ 2017-03-07T16:51:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/amount-of-epithelioid-differentiation-is-a-predictor-of-survival-in-malignant-pleural-mesothelioma-2/ 2017-03-07T16:57:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-controlling-nutritional-status-score-is-a-significant-independent-predictor-of-poor-prognosis-in-patients-with-malignant-pleural-mesothelioma/ 2017-03-10T20:28:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/is-less-also-better-a-single-institution-experience-on-treatment-of-early-stage-malignant-pleural-mesothelioma/ 2017-03-10T20:32:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/recommendations-for-the-diagnosis-and-management-of-asbestos-related-pleural-and-pulmonary-disease/ 2017-03-13T17:54:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-fibres-detected-by-scanning-electron-microscopy-in-the-gallbladder-of-patients-with-malignant-pleural-mesothelioma-mpm-2/ 2017-03-14T13:45:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/non-hodgkin-lymphoma-and-pleural-mesothelioma-in-a-person-exposed-to-asbestos/ 2017-03-15T15:21:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioid-reaction-following-talc-pleurodesis-a-case-report/ 2017-03-15T15:32:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-tumour-thickness-on-survival-after-radical-radiation-and-surgery-in-malignant-pleural-mesothelioma/ 2017-03-17T13:52:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-pilot-study-of-volumetric-modulated-arc-therapy-for-malignant-pleural-mesothelioma-2/ 2017-03-17T14:07:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/physical-function-and-health-related-quality-of-life-in-patients-undergoing-surgical-treatment-for-malignant-pleural-mesothelioma/ 2017-03-17T14:13:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-safety-and-activity-of-pembrolizumab-in-patients-with-malignant-pleural-mesothelioma-keynote-028-preliminary-results-from-a-non-randomised-open-label-phase-1b-trial/ 2017-03-17T14:20:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-the-diagnostic-performance-of-fibulin-3-and-mesothelin-in-patients-with-pleural-effusions-from-malignant-mesothelioma/ 2017-03-23T16:36:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelin-promotes-epithelial-to-mesenchymal-transition-and-tumorigenicity-of-human-lung-cancer-and-mesothelioma-cells/ 2017-03-23T16:44:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/integrated-analysis-of-somatic-mutations-and-immune-microenvironment-in-malignant-pleural-mesothelioma/ 2017-03-28T12:45:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelin-promoter-variants-are-associated-with-increased-soluble-mesothelin-related-peptide-levels-in-asbestos-exposed-individuals/ 2017-03-28T12:55:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/prostaglandin-e2-mediated-adenosinergic-effects-on-cd14-cells-self-amplifying-immunosuppression-in-cancer/ 2017-03-28T13:02:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-bap1-a-new-paradigm-for-mesothelioma/ 2017-03-28T13:10:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/improved-outcomes-with-modern-lung-sparing-trimodality-therapy-in-patients-with-malignant-pleural-mesothelioma/ 2017-03-28T13:19:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/developing-asbestos-job-exposure-matrix-using-occupation-and-industry-specific-exposure-data-1984-2008-in-republic-of-korea/ 2017-03-28T13:24:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/pericardial-mesothelioma-presenting-as-a-suspected-st-elevation-myocardial-infarction/ 2017-03-28T13:29:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/intensity-modulated-radiation-therapy-after-extra-pleural-pneumonectomy-for-malignant-pleural-mesothelioma-is-feasible-without-fatal-pulmonary-toxicity-and-provides-good-survival/ 2017-04-04T14:59:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-second-case-of-pericardial-mesothelioma-mimicking-systemic-lupus-erythematosus-in-the-literature-in-over-30-years-a-case-report/ 2017-04-04T15:08:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/histopathologic-features-predict-survival-in-diffuse-pleural-malignant-mesothelioma-on-pleural-biopsies/ 2017-04-04T15:26:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/serum-hmgb1-as-a-potential-biomarker-for-patients-with-asbestos-related-diseases/ 2017-04-04T15:39:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/transcriptomic-analysis-of-the-claudin-interactome-in-malignant-pleural-mesothelioma-evaluation-of-the-effect-of-disease-phenotype-asbestos-exposure-and-cdkn2a-deletion-status/ 2017-04-07T19:16:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/fty720-inhibits-mesothelioma-growth-in-vitro-and-in-a-syngeneic-mouse-model/ 2017-04-10T19:18:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-proteomic-analysis-of-the-malignant-mesothelioma-secretome-using-itraq/ 2017-04-18T16:01:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-1-dose-escalation-study-of-pegylated-arginine-deiminase-cisplatin-and-pemetrexed-in-patients-with-argininosuccinate-synthetase-1-deficient-thoracic-cancers/ 2017-04-18T16:30:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-novel-brca1-associated-protein-1-isoform-affects-response-of-mesothelioma-cells-to-drugs-impairing-brca1-mediated-dna-repair/ 2017-04-18T16:22:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/analysis-of-fibulin-3-after-exposure-to-asbestos-like-fibers/ 2017-04-18T16:30:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-single-institution-experience-of-101-patients-over-a-15-year-period/ 2017-04-18T17:58:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/cd44-and-its-ligand-hyaluronan-as-potential-biomarkers-in-malignant-pleural-mesothelioma-evidence-and-perspectives/ 2017-04-18T18:02:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidemiology-of-environmental-exposure-and-malignant-mesothelioma/ 2017-04-18T18:05:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/folic-acid-phenotype-fap-is-a-superior-biomarker-predicting-response-to-pemetrexed-based-chemotherapy-in-malignant-pleural-mesothelioma/ 2017-04-25T15:38:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleurectomy-decortication-in-malignant-pleural-mesothelioma-are-different-surgical-techniques-associated-with-different-outcomes-results-from-a-multicentre-study/ 2017-04-25T15:46:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/three-dimensional-finite-element-based-deformable-image-registration-for-evaluation-of-pleural-cavity-irradiation-during-photodynamic-therapy/ 2017-04-25T15:54:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/prophylactic-radiotherapy-for-procedure-tract-metastases-in-mesothelioma-a-review/ 2017-04-25T16:08:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/can-ct-and-mr-shape-and-textural-features-differentiate-benign-versus-malignant-pleural-lesions/ 2017-04-25T16:15:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/spotlight-on-bevacizumab-and-its-potential-in-the-treatment-of-malignant-pleural-mesothelioma-the-evidence-to-date/ 2017-04-25T16:20:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-the-platelet-derived-growth-factor-receptor-beta-pdgfrb-using-gene-silencing-crenolanib-besylate-or-imatinib-mesylate-hampers-the-malignant-phenotype-of-mesothelioma-cell-lines/ 2017-04-25T16:24:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/mir-130a-as-a-diagnostic-marker-to-differentiate-malignant-mesothelioma-from-lung-adenocarcinoma-in-pleural-effusion-cytology/ 2017-05-02T13:59:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-mesothelioma-in-doll-manufacture-possible-asbestos-exposure/ 2017-05-02T14:08:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/propensity-matched-comparison-of-extrapleural-pneumonectomy-and-pleurectomydecortication-for-mesothelioma-patients/ 2017-05-02T14:30:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/plasmatic-extracellular-vesicle-micrornas-in-malignant-pleural-mesothelioma-and-asbestos-exposed-subjects-suggest-a-2-mirna-signature-as-potential-biomarker-of-disease/ 2017-05-09T12:38:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-yap-in-malignant-pleural-mesothelioma/ 2017-05-09T12:44:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/significant-clinical-benefit-of-pemetrexed-based-chemotherapy-for-advanced-diffuse-malignant-peritoneal-mesothelioma-a-case-presentation/ 2017-05-09T12:49:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/synergistic-anti-tumor-effect-of-bullfrog-sialic-acid-binding-lectin-and-pemetrexed-in-malignant-mesothelioma/ 2017-05-09T12:55:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/fibronectin-and-hepatocyte-growth-factor-produced-by-lung-fibroblasts-augment-migration-and-invasion-of-malignant-pleural-mesothelioma-cells/ 2017-05-17T15:37:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-mutations-in-high-grade-meningioma-implications-for-patient-care/ 2017-05-17T15:43:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/induction-chemotherapy-extrapleural-pneumonectomy-and-adjuvant-radiotherapy-for-malignant-pleural-mesothelioma/ 2017-05-17T16:34:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/successful-lung-sparing-resection-of-synchronous-pleural-mesothelioma-and-contralateral-lung-cancer/ 2017-05-17T16:34:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/multiple-malignant-epithelioid-mesotheliomas-of-the-liver-and-greater-omentum-a-case-report-and-review-of-the-literature/ 2017-05-17T16:40:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/car-t-cell-therapy-for-lung-cancer-and-malignant-pleural-mesothelioma/ 2017-05-17T16:49:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-significance-of-soluble-mesothelin-in-malignant-pleural-mesothelioma-a-meta-analysis/ 2017-05-23T20:04:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-and-peritoneal-mesotheliomas-in-the-friuli-venezia-giulia-register-data-analysis-from-1995-to-2015-in-northeastern-italy/ 2017-05-23T20:13:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidemiology-of-mesothelioma-of-the-pericardium-and-tunica-vaginalis-testis/ 2017-05-23T20:24:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/diode-pumped-laser-for-lung-sparing-surgical-treatment-of-malignant-pleural-mesothelioma/ 2017-05-23T20:28:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/comparison-of-outcomes-following-a-cytological-or-histological-diagnosis-of-malignant-mesothelioma/ 2017-05-31T13:43:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/viroimmunotherapy-of-thoracic-cancers/ 2017-05-30T18:36:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-inhibition-of-fgf-receptor-1-activity-mediates-sorafenib-antiproliferative-effects-in-human-malignant-pleural-mesothelioma-tumor-initiating-cells/ 2017-05-30T18:56:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-and-radiation-therapy-for-malignant-pleural-mesothelioma/ 2017-05-30T19:03:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-subset-of-malignant-mesotheliomas-in-young-adults-are-associated-with-recurrent-ewsr1fus-atf1-fusions/ 2017-05-30T19:08:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/dose-time-response-association-between-occupational-asbestos-exposure-and-pleural-mesothelioma/ 2017-05-30T19:15:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/induction-of-il-17-production-from-human-peripheral-blood-cd4-cells-by-asbestos-exposure/ 2017-05-30T19:24:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/whole-exome-sequencing-of-an-asbestos-induced-wild-type-murine-model-of-malignant-mesothelioma/ 2017-06-07T15:13:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/improved-diagnosis-and-prognostication-of-patients-with-pleural-malignant-mesothelioma-using-biomarkers-in-pleural-effusions-and-peripheral-blood-samples-a-short-report/ 2017-06-07T15:29:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/dclk1-is-correlated-with-met-and-erk5-expression-and-associated-with-prognosis-in-malignant-pleural-mesothelioma/ 2017-06-07T15:47:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/unusual-contiguous-soft-tissue-spread-of-advanced-malignant-mesothelioma-detected-by-fdg-petct/ 2017-06-07T15:57:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-cxcr4-with-68gapentixafor-a-suitable-theranostic-approach-in-pleural-mesothelioma/ 2017-06-13T13:18:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-i-trial-of-cediranib-in-combination-with-cisplatin-and-pemetrexed-in-chemo-naive-patients-with-unresectable-malignant-pleural-mesothelioma-swog-s0905/ 2017-06-13T13:29:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/deregulation-of-mirnas-in-malignant-pleural-mesothelioma-is-associated-with-prognosis-and-suggests-an-alteration-of-cell-metabolism/ 2017-06-13T13:35:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/connexin-43-enhances-bax-activation-via-jnk-activation-in-sunitinib-induced-apoptosis-in-mesothelioma-cells/ 2017-06-13T13:45:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/first-line-chemotherapy-with-pemetrexed-plus-cisplatin-for-malignant-peritoneal-mesothelioma/ 2017-06-13T14:06:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-for-early-diagnosis-of-malignant-mesothelioma-do-we-need-another-moonshot/ 2017-06-13T14:10:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/induction-chemotherapy-vs-post-operative-adjuvant-therapy-for-malignant-pleural-mesothelioma/ 2017-06-13T14:15:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/tissue-specific-significance-of-bap1-gene-mutation-in-prognostic-prediction-and-molecular-taxonomy-among-different-types-of-cancer/ 2017-06-21T19:59:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-continues-to-increase-even-40-years-after-exposure-evidence-from-long-term-epidemiological-observation/ 2017-06-22T15:46:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/gata3-immunohistochemistry-for-distinguishing-sarcomatoid-and-desmoplastic-mesothelioma-from-sarcomatoid-carcinoma-of-the-lung/ 2017-06-22T15:57:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/posttranscriptional-regulation-controls-calretinin-expression-in-malignant-pleural-mesothelioma/ 2017-06-22T16:14:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/pro-oxidant-activity-of-sulforaphane-and-cisplatin-potentiates-apoptosis-and-simultaneously-promotes-autophagy-in-malignant-mesothelioma-cells/ 2017-06-22T16:23:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunohistochemical-evaluation-of-two-antibodies-against-pd-l1-and-httpwww-mesothelioma-line-comwp-login-phpactionlogout_wpnonced22f9156abprognostic-significance-of-pd-l1-expression-in-epithel/ 2017-06-22T16:29:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/chest-pain-and-recurrent-chylothorax-an-unusual-presentation-of-malignant-pleural-mesothelioma/ 2017-06-29T19:55:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-with-marked-lymphatic-involvement-a-report-of-two-autopsy-cases/ 2017-06-30T13:43:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumour-suppressor-micrornas-contribute-to-the-regulation-of-pd-l1-expression-in-malignant-pleural-mesothelioma/ 2017-06-30T13:52:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgery-as-part-of-radical-treatment-for-malignant-pleural-mesothelioma/ 2017-06-30T14:05:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-malignant-peritoneal-mesothelioma-suggesting-the-utility-of-combining-double-contrast-radiography-and-endoscopy-with-computed-tomography-for-diagnosis/ 2017-06-30T14:11:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/jq1-a-bet-inhibitor-synergizes-with-cisplatin-and-induces-apoptosis-in-highly-chemoresistant-malignant-pleural-mesothelioma-cells/ 2017-07-05T15:15:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/cap-dependent-translational-control-of-oncolytic-measles-virus-infection-in-malignant-mesothelioma/ 2017-07-05T15:25:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-management-strategies-for-peritoneal-mesothelioma/ 2017-07-05T15:28:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-asbestos-fibre-burden-in-human-lungs-new-insights-into-the-chrysotile-debate/ 2017-07-05T15:38:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/promising-investigational-drug-candidates-in-phase-i-and-phase-ii-clinical-trials-for-mesothelioma/ 2017-07-07T17:04:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/cost-effectiveness-analysis-of-additional-bevacizumab-to-pemetrexed-plus-cisplatin-for-malignant-pleural-mesothelioma-based-on-the-maps-trial/ 2017-07-07T17:09:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/association-between-clinicopathological-factors-and-genomic-abnormalities-detected-by-fish-analysis-in-epithelioid-diffuse-malignant-pleural-mesothelioma/ 2017-07-12T18:28:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/guidelines-for-pathologic-diagnosis-of-malignant-mesothelioma-2017-update-of-the-consensus-statement-from-the-international-mesothelioma-interest-group/ 2017-07-12T18:41:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-suppressor-candidate-2-tusc2-fus-1-and-human-cancers/ 2017-07-18T13:48:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-the-epigenome-in-malignant-pleural-mesothelioma/ 2017-07-18T13:56:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/drug-development-against-the-hippo-pathway-in-mesothelioma/ 2017-07-18T14:16:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/radio-immunotherapy-and-chemo-immunotherapy-as-a-novel-treatment-paradigm-in-malignant-pleural-mesothelioma/ 2017-07-18T14:25:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-eukaryotic-protein-translation-in-mesothelioma/ 2017-07-18T14:29:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-for-malignant-pleural-mesothelioma-current-status-and-future-directions/ 2017-07-18T14:39:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-systemic-therapy-against-malignant-pleural-mesothelioma/ 2017-07-18T14:45:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/magnetic-nanoparticles-based-therapy-for-malignant-mesothelioma/ 2017-07-25T13:04:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/tremelimumab-as-second-line-or-third-line-treatment-in-relapsed-malignant-mesothelioma-determine-a-multicentre-international-randomised-double-blind-placebo-controlled-phase-2b-trial/ 2017-07-25T13:24:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-dose-palliative-radiotherapy-for-malignant-pleural-mesothelioma/ 2017-07-25T14:02:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/abdominal-wall-morbidity-following-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy/ 2017-07-25T14:22:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-checkpoint-therapy-of-mesothelioma-pre-clinical-bases-and-clinical-evidences/ 2017-07-25T14:28:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/remote-recurrence-of-benign-multicystic-peritoneal-mesothelioma/ 2017-07-25T14:34:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/intraoperative-adjuncts-for-malignant-pleural-mesothelioma/ 2017-07-25T14:44:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/low-dose-photon-irradiation-induces-invasiveness-through-the-sdf-1%ce%b1cxcr4-pathway-in-malignant-mesothelioma-cells/ 2017-08-01T20:20:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-application-of-bap1-immunohistochemistry-to-differentiate-pleural-mesothelioma-from-metastatic-pleural-tumors/ 2017-08-02T13:50:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/lung-cancer-in-a-patient-with-predominantly-short-tremolite-fibers-in-his-lung/ 2017-08-02T14:10:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/functional-image-guided-radiation-therapy-planning-in-volumetric-modulated-arc-therapy-for-patients-with-malignant-pleural-mesothelioma/ 2017-08-02T14:23:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-drive-for-self-assertion-and-the-reality-principle-in-a-patient-with-malignant-pleural-mesothelioma-the-history-of-giulia/ 2017-08-02T14:28:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/therapeutic-radiation-for-lymphoma-and-risk-of-second-primary-malignant-mesothelioma/ 2017-08-02T14:33:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/low-dose-photon-irradiation-induces-invasiveness-through-the-sdf-1%ce%b1cxcr4-pathway-in-malignant-mesothelioma-cells-2/ 2017-08-02T14:49:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-differential-diagnosis-between-pleural-sarcomatoid-mesothelioma-and-spindle-cellpleomorphic-sarcomatoid-carcinomas-of-the-lung-evidence-based-guidelines-from-the-international-mesothelioma-pan/ 2017-08-08T13:55:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-value-of-medical-thoracoscopy-in-malignant-pleural-effusion/ 2017-08-08T14:01:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/italian-pool-of-asbestos-workers-cohorts-mortality-trends-of-asbestos-related-neoplasms-after-long-time-since-first-exposure/ 2017-08-08T14:09:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/indolent-peritoneal-mesothelioma-pi3k-mtor-inhibitors-as-a-novel-therapeutic-strategy/ 2017-08-08T14:16:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/microrna-expression-in-malignant-pleural-mesothelioma-and-asbestosis-a-pilot-study/ 2017-08-08T14:35:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-segmentation-for-photodynamic-therapy-planning/ 2017-08-10T16:54:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/isolated-thoracic-perfusion-with-chemofiltration-for-progressive-malignant-pleural-mesothelioma/ 2017-08-10T16:58:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-state-of-the-art-and-advanced-cell-therapy/ 2017-08-15T14:26:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelioid-malignant-mesothelioma-metastatic-to-the-skin-a-case-report-and-review-of-the-literature/ 2017-08-15T14:37:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/isolated-thoracic-perfusion-with-chemofiltration-for-progressive-malignant-pleural-mesothelioma-2/ 2017-08-15T14:37:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-segmentation-for-photodynamic-therapy-planning-2/ 2017-08-15T14:47:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-outcomes-of-cancer-directed-surgery-for-malignant-pleural-mesothelioma-propensity-score-matching-analysis/ 2017-08-21T14:24:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/exposure-to-nano-size-titanium-dioxide-causes-oxidative-damages-in-human-mesothelial-cells-the-crystal-form-rather-than-size-of-particle-contributes-to-cytotoxicity/ 2017-08-22T15:28:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-outcomes-of-cancer-directed-surgery-for-malignant-pleural-mesothelioma-propensity-score-matching-analysis-2/ 2017-08-22T15:34:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/heart-dosimetry-is-correlated-with-risk-of-radiation-pneumonitis-after-lung-sparing-hemithoracic-pleural-intensity-modulated-radiation-therapy-for-malignant-pleural-mesothelioma/ 2017-08-22T15:43:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluating-the-effect-of-immune-cells-on-the-outcome-of-patients-with-mesothelioma/ 2017-08-22T15:50:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-alcam-cd166-and-pd-l1-cd274-independently-predicts-shorter-survival-in-malignant-pleural-mesothelioma/ 2017-08-22T15:59:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-imaging-and-workup-of-malignant-pleural-mesothelioma/ 2017-08-29T15:17:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/national-cancer-data-base-report-on-pneumonectomy-versus-lung-sparing-surgery-for-malignant-pleural-mesothelioma/ 2017-08-29T15:31:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/survival-in-good-performance-malignant-pleural-mesothelioma-patients-prognostic-factors-and-predictors-of-response/ 2017-08-29T15:37:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/pathological-complete-response-in-malignant-pleural-mesothelioma-patients-following-induction-chemotherapy-predictive-factors-and-outcomes/ 2017-08-29T15:44:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/regulation-of-microrna-using-promising-dietary-phytochemicals-possible-preventive-and-treatment-option-of-malignant-mesothelioma/ 2017-08-29T15:53:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/chest-ultrasonography-in-health-surveillance-of-asbestos-related-pleural-disease/ 2017-08-29T16:05:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-pleural-cavity-irradiation-after-decortication-with-helical-tomotherapy/ 2017-08-29T16:13:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/ambient-asbestos-fiber-concentrations-and-long-term-trends-in-pleural-mesothelioma-incidence-between-urban-and-rural-areas-in-the-united-states-1973-2012/ 2017-09-05T15:16:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/chimeric-antigen-receptor-car-t-cell-therapy-for-malignant-pleural-mesothelioma-mpm/ 2017-09-05T15:21:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-staging-of-malignant-pleural-mesothelioma-current-perspectives/ 2017-09-05T15:33:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-radical-radiotherapy-in-the-management-of-malignant-pleural-mesothelioma-a-systematic-review/ 2017-09-05T15:40:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/near-infrared-intraoperative-imaging-can-successfully-identify-malignant-pleural-mesothelioma-after-neoadjuvant-chemotherapy/ 2017-09-05T15:45:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/estimation-of-the-global-burden-of-mesothelioma-deaths-from-incomplete-national-mortality-data/ 2017-09-05T15:53:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-myc-sensitizes-malignant-mesothelioma-cells-to-pak-blockage-induced-cytotoxicity/ 2017-09-05T16:01:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/nintedanib-plus-pemetrexedcisplatin-in-patients-with-malignant-pleural-mesothelioma-phase-ii-results-from-the-randomized-placebo-controlled-lume-meso-trial/ 2017-09-12T15:14:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-epithelioid-bap1-negative-and-p16-positive-phenotype-predicts-prolonged-survival-in-pleural-mesothelioma/ 2017-09-12T15:21:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/secondary-hypertrophic-osteoarthropathy-caused-by-non-pleural-or-pulmonary-tumors/ 2017-09-12T15:29:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/radiotherapy-for-the-treatment-of-malignant-pleural-mesothelioma/ 2017-09-12T15:40:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinicopathologic-and-genetic-characteristics-of-young-patients-with-pleural-diffuse-malignant-mesothelioma/ 2017-09-12T15:36:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/oncolytic-viral-therapy-for-mesothelioma/ 2017-09-12T15:44:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-for-early-diagnosis-of-malignant-mesothelioma-do-we-need-another-moonshot-2/ 2017-09-12T16:04:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/assessment-of-patient-reported-outcome-measures-in-pleural-interventions/ 2017-09-12T16:04:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/safety-and-activity-of-microrna-loaded-minicells-in-patients-with-recurrent-malignant-pleural-mesothelioma-a-first-in-man-phase-1-open-label-dose-escalation-study/ 2017-09-12T16:10:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/microrna-31-regulates-chemosensitivity-in-malignant-pleural-mesothelioma/ 2017-09-19T19:06:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-significance-of-neutrophil-to-lymphocyte-ratio-in-patients-with-malignant-pleural-mesothelioma-a-meta-analysis/ 2017-09-20T13:43:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/identification-of-alk-rearrangements-in-malignant-peritoneal-mesothelioma/ 2017-09-20T13:53:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-pd-l1pd-1-pathway-promotes-dysfunction-but-not-exhaustion-in-tumor-responding-t-cells-from-pleural-effusions-in-lung-cancer-patients/ 2017-09-20T13:59:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/determination-of-pd-l1-expression-in-effusions-from-mesothelioma-by-immuno-cytochemical-staining/ 2017-09-20T14:10:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-intracavitary-administration-of-curcumin-for-the-treatment-of-sarcomatoid-mesothelioma/ 2017-09-20T14:17:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-for-recurrence-after-extrapleural-pneumonectomy-for-malignant-pleural-mesothelioma-a-single-institution-experience/ 2017-09-20T14:29:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/role-of-proton-coupled-folate-transporter-in-pemetrexed-resistance-of-mesothelioma-clinical-evidence-and-new-pharmacological-tools/ 2017-09-26T17:54:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-and-predictive-role-of-18-ffluorodeoxyglucose-positron-emission-tomography-fdg-pet-in-patients-with-unresectable-malignant-pleural-mesothelioma-mpm-treated-with-up-front-pemetrexed-ba/ 2017-09-26T18:08:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/non-occupational-exposure-to-asbestos-and-risk-of-pleural-mesothelioma-review-and-meta-analysis/ 2017-09-26T18:16:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-value-of-delayed-phase-enhanced-imaging-in-malignant-pleural-mesothelioma/ 2017-09-26T18:24:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/diffuse-peritoneal-mesothelioma-a-case-series-of-62-patients-including-paraoccupational-exposures-to-chrysotile-asbestos/ 2017-09-26T18:32:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/weight-of-evidence-analysis-for-assessing-the-genotoxic-potential-of-carbon-nanotubes/ 2017-09-26T18:38:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/soluble-mesothelin-related-peptides-to-monitor-recurrence-after-resection-of-pleural-mesothelioma/ 2017-10-02T17:46:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-effusion-biomarkers-and-computed-tomography-findings-in-diagnosing-malignant-pleural-mesothelioma-a-retrospective-study-in-a-single-center/ 2017-10-03T20:36:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-atp-competitive-akt-inhibitor-afuresertib-suppresses-the-proliferation-of-malignant-pleural-mesothelioma-cells/ 2017-10-04T14:34:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-report-of-primary-pericardial-malignant-mesothelioma-treated-with-pemetrexed-and-cisplatin/ 2017-10-04T14:40:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/influence-of-pleurectomy-and-decortication-in-health-related-quality-of-life-among-patients-with-malignant-pleural-mesothelioma/ 2017-10-04T14:47:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/multicentric-initial-experience-with-the-use-of-the-pressurized-intraperitoneal-aerosol-chemotherapy-pipac-in-the-management-of-unresectable-peritoneal-carcinomatosis/ 2017-10-04T15:35:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/downregulation-of-mir-99alet-7cmir-125b-mirna-cluster-predicts-clinical-outcome-in-patients-with-unresected-malignant-pleural-mesothelioma/ 2017-10-09T15:58:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/mir-30d-is-related-to-asbestos-exposure-and-inhibits-migration-and-invasion-in-nci-h2452-cells/ 2017-10-10T13:56:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/low-dose-photon-irradiation-induces-invasiveness-through-the-sdf-1%ce%b1cxcr4-pathway-in-malignant-mesothelioma-cells-3/ 2017-10-10T14:50:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-randomized-phase-ii-trial-of-adjuvant-galinpepimut-s-wt-1-analog-peptide-vaccine-after-multimodality-therapy-for-patients-with-malignant-pleural-mesothelioma/ 2017-10-10T14:56:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/advances-in-systemic-therapy-for-malignant-mesothelioma-future-perspectives/ 2017-10-10T15:04:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-accuracy-of-brca1-associated-protein-1-in-malignant-mesothelioma-a-meta-analysis/ 2017-10-10T15:17:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/estimating-past-inhalation-exposure-to-asbestos-a-tool-for-risk-attribution-and-disease-screening/ 2017-10-18T21:18:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-concepts-in-the-treatment-of-malignant-pleural-mesothelioma/ 2017-10-18T21:21:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/application-of-3d-mass-spectrometry-imaging-to-tkis/ 2017-10-18T21:25:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/cutaneous-presentation-of-mesothelioma-with-a-sarcomatoid-transformation/ 2017-10-24T13:32:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/annals-express-biomarkers-in-mesothelioma/ 2017-10-24T13:37:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-combination-of-mtap-and-bap1-immunohistochemistry-in-pleural-effusion-cytology-for-the-diagnosis-of-mesothelioma/ 2017-10-24T13:40:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-revised-staging-system-for-malignant-pleural-mesothelioma-based-on-surveillance-epidemiology-and-end-results-database/ 2017-10-24T13:45:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-mesothelin-receptors-with-drug-loaded-bacterial-nanocells-suppresses-human-mesothelioma-tumour-growth-in-mouse-xenograft-models/ 2017-10-24T13:55:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/loss-of-brca-associated-protein-1-expression-in-malignant-mesothelioma-and-its-diagnostic-application/ 2017-10-24T13:52:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/extended-pleurectomy-decortication-for-malignant-pleural-mesothelioma-in-the-elderly-the-need-for-an-inclusive-yet-selective-approach/ 2017-10-24T15:31:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effects-of-improving-the-mesothelioma-surveillance-network-on-sensitivity-timeliness-in-reporting-and-asbestos-exposure-assessment/ 2017-10-31T12:51:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-and-histopathological-characterization-of-the-tumor-immune-microenvironment-in-advanced-stage-of-malignant-pleural-mesothelioma/ 2017-10-31T13:24:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/video-assisted-thoracoscopic-and-open-chest-surgery-in-diagnosis-and-treatment-of-malignant-pleural-diseases/ 2017-10-31T13:30:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/loss-of-bap1-expression-in-atypical-mesothelial-proliferations-helps-to-predict-malignant-mesothelioma/ 2017-10-31T13:38:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidemiology-of-malignant-peritoneal-mesothelioma-a-population-based-study/ 2017-10-31T13:46:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/chemical-profiling-of-primary-mesothelioma-cultures-defines-subtypes-with-different-expression-profiles-and-clinical-responses/ 2017-10-31T13:55:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-pharmacogenomic-profiling-of-malignant-pleural-mesothelioma-identifies-a-subgroup-sensitive-to-fgfr-inhibition/ 2017-10-31T13:58:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/chimeric-antigen-receptor-car-t-cell-therapy-for-thoracic-malignancies/ 2017-11-07T14:21:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-l1-expression-associated-with-worse-survival-outcome-in-malignant-pleural-mesothelioma/ 2017-11-07T14:29:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-microrna-to-improve-diagnostic-and-therapeutic-approaches-for-malignant-mesothelioma/ 2017-11-07T14:36:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/cancer-antigen-profiling-for-malignant-pleural-mesothelioma-immunotherapy-expression-and-coexpression-of-mesothelin-cancer-antigen-125-and-wilms-tumor-1/ 2017-11-07T14:45:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effect-of-aquaporin-1-inhibition-on-vasculogenic-mimicry-in-malignant-mesothelioma/ 2017-11-07T14:52:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-link-between-the-fibroblast-growth-factor-axis-and-the-mir-16-family-reveals-potential-new-treatment-combinations-in-mesothelioma/ 2017-11-07T15:06:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-review-of-bevacizumab-in-the-treatment-of-malignant-pleural-mesothelioma/ 2017-11-07T15:14:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-promise-and-challenges-of-exploiting-the-proton-coupled-folate-transporter-for-selective-therapeutic-targeting-of-cancer/ 2017-11-14T14:22:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-30-year-mortality-and-respiratory-morbidity-study-of-refractory-ceramic-fiber-workers/ 2017-11-14T14:29:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytological-profile-of-a-case-of-malignant-mesothelioma-of-pleura-with-supraclavicular-lymph-node-metastasis/ 2017-11-14T14:54:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/4egi-1-represses-cap-dependent-translation-and-regulates-genome-wide-translation-in-malignant-pleural-mesothelioma/ 2017-11-14T15:06:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/dysregulated-expression-of-the-microrna-mir-137-and-its-target-yb-1-contribute-to-the-invasive-characteristics-of-malignant-pleural-mesothelioma/ 2017-11-14T15:13:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-in-australia-a-review/ 2017-11-14T15:17:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-image-cytometric-technique-is-a-concise-method-to-detect-adenoviruses-and-host-cell-proteins-and-to-monitor-the-infection-and-cellular-responses-induced/ 2017-11-14T15:24:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-analysis-of-novel-microrna-mimic-sequences-in-cancer-cells-reveals-lack-of-specificity-in-stem-loop-rt-qpcr-based-microrna-detection/ 2017-11-20T16:35:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/temporal-and-spatial-heterogeneity-of-programmed-cell-death-1-ligand-1-expression-in-malignant-mesothelioma/ 2017-11-20T16:38:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-cell-free-and-concentrated-ascites-reinfusion-therapy-for-palliative-care-in-a-patient-with-malignant-pleural-mesothelioma-a-case-report/ 2017-11-20T16:43:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-dose-irradiation-after-pleurectomy-decortication-or-biopsy-for-pleural-mesothelioma-treatment/ 2017-11-20T16:46:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/effect-of-an-indwelling-pleural-catheter-vs-talc-pleurodesis-on-hospitalization-days-in-patients-with-malignant-pleural-effusion-the-ample-randomized-clinical-trial/ 2017-11-28T20:07:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/abundant-expression-of-tim-3-lag-3-pd-1-and-pd-l1-as-immunotherapy-checkpoint-targets-in-effusions-of-mesothelioma-patients/ 2017-11-28T20:13:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/human-canonical-cd157-bst1-is-an-alternatively-spliced-isoform-masking-a-previously-unidentified-primate-specific-exon-included-in-a-novel-transcript/ 2017-11-28T20:16:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/proton-therapy-for-malignant-pleural-mesothelioma-a-three-case-series-describing-the-clinical-and-dosimetric-advantages-of-proton-based-therapy/ 2017-11-28T20:22:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-case-report-and-insight-into-a-novel-tumor-suppressor/ 2017-11-28T20:25:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/search-for-biomarkers-of-asbestos-exposure-and-asbestos-induced-cancers-in-investigations-of-the-immunological-effects-of-asbestos/ 2017-11-28T20:29:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/matrix-metalloproteinases-polymorphisms-as-prognostic-biomarkers-in-malignant-pleural-mesothelioma/ 2017-11-28T20:36:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/plasma-fibulin-3-as-a-potential-biomarker-for-patients-with-asbestos-related-diseases-in-the-han-population/ 2017-12-05T15:35:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/diaphragm-and-lung-preserving-surgery-with-hyperthermic-chemotherapy-for-malignant-pleural-mesothelioma-a-10-year-experience/ 2017-12-05T15:45:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/patterns-of-care-and-survival-among-patients-with-malignant-mesothelioma-in-the-united-states/ 2017-12-05T15:51:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-the-resected-lymphohistiocytoid-mesothelioma-bap1-is-a-key-of-accurate-diagnosis/ 2017-12-05T16:01:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-presentation-diagnosis-classification-and-management-of-peritoneal-mesothelioma-a-review/ 2017-12-05T16:06:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/phlebotomy-as-a-preventive-measure-for-crocidolite-induced-mesothelioma-in-male-rats/ 2017-12-05T16:17:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/elevated-brain-natriuretic-peptide-bnp-is-an-early-marker-for-patients-at-risk-for-complications-after-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-crs%e2%80%89%e2%80%89hipe/ 2017-12-05T16:23:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/recent-advances-in-the-diagnosis-of-malignant-mesothelioma-focus-on-approach-in-challenging-cases-and-in-limited-tissue-and-cytologic-samples/ 2017-12-12T19:42:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-of-sonographic-and-biological-pleurodesis-indicators-of-malignant-pleural-effusion-simple-protocol-of-a-randomised-controlled-trial/ 2017-12-12T19:49:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/national-trends-in-the-epidemiology-of-malignant-pleural-mesothelioma-a-national-cancer-data-base-study/ 2017-12-12T19:55:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyaluronic-acid-enhances-cell-migration-and-invasion-via-the-yap1-taz-rhamm-axis-in-malignant-pleural-mesothelioma/ 2017-12-12T19:58:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/pseudomesotheliomatous-carcinoma-of-the-pleura-an-autopsy-case-of-metastasis-from-a-g-csf-producing-anaplastic-carcinoma-of-the-pancreas/ 2017-12-14T18:45:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/modulation-of-reactive-oxygen-species-via-erk-and-stat3-dependent-signalling-are-involved-in-the-response-of-mesothelioma-cells-to-exemestane/ 2017-12-14T18:49:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-cxcr4-with-68gapentixafor-a-suitable-theranostic-approach-in-pleural-mesothelioma-2/ 2017-12-14T18:54:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/predictors-of-trimodality-therapy-and-trends-in-therapy-for-malignant-pleural-mesothelioma/ 2017-12-14T18:58:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/breath-analysis-by-gas-chromatography-mass-spectrometry-and-electronic-nose-to-screen-for-pleural-mesothelioma-a-cross-sectional-case-control-study/ 2017-12-14T19:04:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/complement-protein-c1q-binds-to-hyaluronic-acid-in-the-malignant-pleural-mesothelioma-microenvironment-and-promotes-tumor-growth/ 2017-12-14T19:08:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/risk-of-cancer-associated-with-residential-exposure-to-asbestos-insulation-a-whole-population-cohort-study/ 2018-01-02T19:16:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/endoscopic-ultrasound-guided-fine-needle-aspiration-from-ascites-and-peritoneal-nodules-a-scoping-review/ 2018-01-02T19:21:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/difficulty-in-positive-diagnosis-of-ascites-and-in-differential-diagnosis-of-a-pulmonary-tumor/ 2018-01-02T19:27:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-fibre-burden-in-gallbladder-a-case-study/ 2018-01-02T19:44:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/exhaled-breath-to-screen-for-malignant-pleural-mesothelioma-a-validation-study/ 2018-01-02T19:48:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-epidemiology-of-malignant-mesothelioma-in-women-gender-differences-and-modalities-of-asbestos-exposure/ 2018-01-02T19:53:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-genetic-variant-of-nlrp1-gene-is-associated-with-asbestos-body-burden-in-patients-with-malignant-pleural-mesothelioma/ 2018-01-02T20:03:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/radical-multimodality-therapy-for-malignant-pleural-mesothelioma/ 2018-01-09T14:13:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/biological-responses-to-asbestos-inhalation-and-pathogenesis-of-asbestos-related-benign-and-malignant-disease/ 2018-01-09T14:24:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/focal-adhesion-kinase-a-potential-therapeutic-target-for-pancreatic-cancer-and-malignant-pleural-mesothelioma/ 2018-01-09T14:34:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/malign-pleural-mesothelioma-so-far-an-undefeated-tumor/ 2018-01-09T14:41:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/chest-physician-reported-work-related-long-latency-respiratory-disease-in-great-britain/ 2018-01-09T14:54:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-nomogram-to-predict-prognosis-in-malignant-pleural-mesothelioma/ 2018-01-09T15:10:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/omentin-a-novel-adipokine-in-respiratory-diseases/ 2018-01-09T15:13:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/induction-of-protein-citrullination-and-auto-antibodies-production-in-murine-exposed-to-nickel-nanomaterials/ 2018-01-16T19:44:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/nuclear-grade-and-necrosis-predict-prognosis-in-malignant-epithelioid-pleural-mesothelioma-a-multi-institutional-study/ 2018-01-16T19:51:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/germline-and-somatic-variant-identification-using-bgiseq-500-and-hiseq-x-ten-whole-genome-sequencing/ 2018-01-16T19:56:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/smarcb1-ini1-baf47-deficient-pleural-malignant-mesothelioma-with-rhabdoid-features/ 2018-01-16T20:00:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarker-integrated-neoadjuvant-dasatinib-trial-in-resectable-malignant-pleural-mesothelioma/ 2018-01-16T20:14:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/genome-evolution-analysis-of-recurrent-testicular-malignant-mesothelioma-by-whole-genome-sequencing/ 2018-01-16T20:17:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/progress-in-the-management-of-advanced-thoracic-malignancies-in-2017/ 2018-01-16T20:39:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-analysis-of-high-mobility-group-box-1-hmgb1-in-histologic-samples-of-malignant-pleural-mesothelioma/ 2018-01-23T15:49:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-with-a-large-prevascular-lymph-node-n1-involvement-or-something-different/ 2018-01-23T15:54:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-as-a-difficult-interdisciplinary-problem/ 2018-01-23T16:06:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-in-situ/ 2018-01-23T16:16:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-of-malignant-pleural-mesothelioma-american-society-of-clinical-oncology-clinical-practice-guideline/ 2018-01-23T16:24:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/ppersonalized-chemosensitivity-assays-for-mesothelioma-is-it-worth-the-effort/ 2018-01-23T16:30:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/heterogeneous-contributing-factors-in-mpm-disease-development-and-progression-biological-advances-and-clinical-implications/ 2018-01-23T16:34:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/large-scale-copy-number-analysis-reveals-variations-in-genes-not-previously-associated-with-malignant-pleural-mesothelioma/ 2018-01-30T15:42:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-rentability-of-close-pleural-biopsy-tru-cut-vs-cope/ 2018-01-30T15:49:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/is-pleurectomy-decortication-superior-to-extrapleural-pneumonectomy-for-patients-with-malignant-pleural-mesothelioma-a-single-institutional-experience/ 2018-01-30T15:55:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/therapeutic-potential-of-targeting-s100a11-in-malignant-pleural-mesothelioma/ 2018-01-30T16:06:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-of-tunica-vaginalis-testis-macroscopic-and-microscopic-features-of-a-very-rare-malignancy/ 2018-01-30T16:17:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/cisplatin-and-pemetrexed-activate-axl-and-axl-inhibitor-bgb324-enhances-mesothelioma-cell-death-from-chemotherapy/ 2018-01-30T16:20:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluating-quality-of-life-and-cost-implications-of-prophylactic-radiotherapy-in-mesothelioma-health-economic-analysis-of-the-smart-trial/ 2018-02-06T14:21:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/single-institution-experience-of-intensity-modulated-radiotherapy-for-malignant-pleural-mesothelioma-at-university-of-catania/ 2018-02-06T14:27:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/content-validity-and-electronic-pro-epro-usability-of-the-lung-cancer-symptom-scale-mesothelioma-lcss-meso-in-mesothelioma-patients/ 2018-02-06T14:35:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/surfing-on-unreliable-waters-a-cross-sectional-study-into-the-content-and-quality-of-online-informational-resources-for-mesothelioma-patients/ 2018-02-06T14:42:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/multiple-intracranial-metastases-from-postoperative-giant-sarcomatoid-malignant-pleural-mesothelioma-a-case-report-and-literature-review/ 2018-02-06T14:46:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/survivin-is-a-negative-prognostic-factor-in-malignant-pleural-effusion/ 2018-02-06T14:50:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-and-survival-of-pleural-mesothelioma-a-record-linkage-study/ 2018-02-12T15:53:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/inflammatory-alteration-of-human-t-cells-exposed-continuously-to-asbestos/ 2018-02-13T15:12:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/anti-tumor-immunotherapy-in-malignant-pleural-mesothelioma/ 2018-02-13T15:23:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/germline-bap1-positive-patients-the-dilemmas-of-cancer-surveillance-and-a-proposed-interdisciplinary-consensus-monitoring-strategy/ 2018-02-13T15:36:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-management-and-future-opportunities-for-peritoneal-metastases-peritoneal-mesothelioma/ 2018-02-13T15:42:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/global-trends-in-mortality-from-malignant-mesothelioma-analysis-of-who-mortality-database-1993-2013/ 2018-02-13T15:53:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-and-thymic-tumors-treatment-challenges-in-outside-a-network-setting/ 2018-02-13T15:59:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/survival-prediction-in-mesothelioma-using-a-scalable-lasso-regression-model-instructions-for-use-and-initial-performance-using-clinical-predictors/ 2018-02-23T18:47:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/secreted-and-tissue-mirnas-as-diagnosis-biomarkers-of-malignant-pleural-mesothelioma/ 2018-02-23T18:53:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-prospective-study-to-investigate-the-role-of-serial-serum-mesothelin-in-monitoring-mesothelioma/ 2018-02-23T18:56:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/intracavitary-therapeutics-for-pleural-malignancies/ 2018-02-23T18:59:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/determinants-of-malignant-pleural-mesothelioma-survival-and-burden-of-disease-in-france-a-national-cohort-analysis/ 2018-02-27T21:02:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-impact-of-inflammation-related-biomarkers-on-overall-survival-of-patients-with-inoperable-malignant-pleural-mesothelioma/ 2018-02-27T21:05:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/changing-health-behaviour-with-rehabilitation-in-thoracic-cancer-a-systematic-review-and-synthesis/ 2018-02-27T21:13:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-clinical-trial-combines-immunotherapy-drugs/ 2018-02-27T21:17:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-for-thoracic-oncology-gone-viral/ 2018-02-27T21:20:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/utility-of-survivin-bap1-and-ki-67-immunohistochemistry-in-distinguishing-epithelioid-mesothelioma-from-reactive-mesothelial-hyperplasia/ 2018-02-27T21:26:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-fiber-length-and-its-relation-to-disease-risk/ 2018-02-27T21:30:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelin-and-osteopontin-as-circulating-markers-of-diffuse-malignant-peritoneal-mesothelioma-a-preliminary-study/ 2018-03-06T14:48:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-c-reactive-protein-albumin-ratio-is-a-novel-significant-prognostic-factor-in-patients-with-malignant-pleural-mesothelioma-a-retrospective-multi-institutional-study/ 2018-03-06T14:59:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/18f-fdg-pet-ct-in-the-management-of-patients-with-malignant-pleural-mesothelioma-being-considered-for-multimodality-therapy-experience-of-a-tertiary-referral-center/ 2018-03-06T15:06:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunohistochemical-expression-of-aquaporin-1-in-fluoro-edenite-induced-malignant-mesothelioma-a-preliminary-report/ 2018-03-06T15:14:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/stem-cells-application-in-thoracic-surgery-current-perspective-and-future-directions/ 2018-03-06T15:18:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/synthetic-lignan-secoisolariciresinol-diglucoside-lgm2605-reduces-asbestos-induced-cytotoxicity-in-an-nrf2-dependent-and-independent-manner/ 2018-03-06T15:25:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/non-incisional-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2018-03-06T15:28:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/implementation-of-hyperthermic-intrathoracic-chemotherapy-hithoc-in-germany/ 2018-03-16T16:54:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/live-cell-mesothelioma-biobank-to-explore-mechanisms-of-tumor-progression/ 2018-03-16T16:59:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/state-of-the-art-advances-in-malignant-pleural-mesothelioma-in-2017/ 2018-03-16T17:02:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/aminopeptidase-n-cd13-as-a-potential-therapeutic-target-in-malignant-pleural-mesothelioma/ 2018-03-16T17:18:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/dna-methylation-profiling-of-asbestos-treated-met5a-cell-line-reveals-novel-pathways-implicated-in-asbestos-response/ 2018-03-16T17:18:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/live-cell-mesothelioma-biobank-to-explore-mechanisms-of-tumor-progression-2/ 2018-03-16T17:21:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/post-irradiation-pericardial-malignant-mesothelioma-with-deletion-of-p16-a-case-report/ 2018-03-22T13:03:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/drug-repurposing-in-malignant-pleural-mesothelioma-a-breath-of-fresh-air/ 2018-03-22T13:10:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/trends-and-the-economic-effect-of-asbestos-bans-and-decline-in-asbestos-consumption-and-production-worldwide/ 2018-03-22T13:23:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/update-on-immunohistochemistry-for-the-diagnosis-of-lung-cancer/ 2018-03-22T13:32:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/value-of-immunocytochemistry-in-differential-diagnosis-of-gastric-adenocarcinoma-reactive-mesothelial-cells-and-malignant-epithelial-mesothelioma-in-metastatic-effusion-fluid/ 2018-03-22T13:58:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/involvement-of-heparanase-in-the-pathogenesis-of-mesothelioma-basic-aspects-and-clinical-applications/ 2018-03-27T15:28:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-presenting-as-mucinous-ascites/ 2018-03-27T15:31:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-yes-associated-protein-down-regulates-pd-l1-cd274-expression-in-human-malignant-pleural-mesothelioma/ 2018-03-27T15:39:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/environmental-asbestos-exposure-and-mesothelioma-cases-in-bari-apulia-region-southern-italy-a-national-interest-site-for-land-reclamation/ 2018-03-27T15:46:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/podoplanin-an-emerging-cancer-biomarker-and-therapeutic-target/ 2018-03-27T15:53:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-psychological-distress-and-care-needs-of-mesothelioma-patients-and-asbestos-exposed-subjects-a-systematic-review-of-published-studies/ 2018-03-27T16:00:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/early-contrast-enhancement-a-novel-magnetic-resonance-imaging-biomarker-of-pleural-malignancy/ 2018-03-27T16:08:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-are-there-imaging-characteristics-associated-with-different-histologic-subtypes-on-computed-tomography/ 2018-04-04T19:31:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/comprehensive-immunoproteogenomic-analyses-of-malignant-pleural-mesothelioma/ 2018-04-06T18:16:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/poor-prognostic-factors-in-patients-with-malignant-pleural-mesothelioma-classified-as-pathological-stage-ib-according-to-the-eighth-edition-tnm-classification/ 2018-04-06T18:22:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/randomised-controlled-trial-to-compare-the-diagnostic-yield-of-positron-emission-tomography-ct-pet-ct-targeted-pleural-biopsy-versus-ct-guided-pleural-biopsy-in-suspected-pleural-malignancy-target/ 2018-04-06T18:31:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-diagnostic-value-of-medical-thoracoscopy-and-long-term-prognostic-analysis/ 2018-04-06T18:39:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-current-aetiology-of-malignant-pleural-effusion-in-the-western-cape-province-south-africa/ 2018-04-10T13:47:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-fiber-concentrations-in-the-lungs-of-brake-repair-workers-an-updated-analysis-using-several-regression-methods-to-handle-non-detectable-measurements/ 2018-04-10T13:53:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-of-malignant-pleural-mesothelioma-with-bone-marrow-metastases/ 2018-04-10T13:59:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-cells-from-pleural-fluids-in-malignant-mesothelioma-patients-reveal-novel-mutations/ 2018-04-17T13:55:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/carbon-nanotubes-and-other-engineered-nanoparticles-induced-pathophysiology-on-mesothelial-cells-and-mesothelial-membranes/ 2018-04-17T14:02:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/fgf2-and-egf-induce-epithelial-mesenchymal-transition-in-malignant-pleural-mesothelioma-cells-via-a-mapkinase-mmp1-signal/ 2018-04-17T14:07:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/mr-imaging-of-pleural-neoplasms/ 2018-04-17T14:14:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/new-perspectives-on-diagnosis-and-therapy-of-malignant-pleural-mesothelioma/ 2018-04-20T17:42:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/pressurized-intraperitoneal-aerosol-chemotherapy-pipac-for-the-treatment-of-malignant-mesothelioma/ 2018-04-23T14:35:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/video-assisted-thoracoscopic-plasmajet-ablation-for-malignant-pleural-mesothelioma/ 2018-04-26T16:18:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-review-of-the-cohorts-with-environmental-and-occupational-mineral-fiber-exposure/ 2018-04-26T16:48:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/putative-cancer-stem-cells-may-be-the-key-target-to-inhibit-cancer-cell-repopulation-between-the-intervals-of-chemoradiation-in-murine-mesothelioma/ 2018-04-30T13:55:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/regulation-of-calretinin-in-malignant-mesothelioma-is-mediated-by-septin-7-binding-to-the-calb2-promoter/ 2018-04-30T15:23:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/in-silico-and-in-vitro-analyses-of-lncrnas-as-potential-regulators-in-the-transition-from-the-epithelioid-to-sarcomatoid-histotype-of-malignant-pleural-mesothelioma-mpm/ 2018-04-30T16:27:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/multicystic-mesothelioma-operative-and-long-term-outcomes-with-cytoreductive-surgery-and-hyperthermic-intra-peritoneal-chemotherapy/ 2018-05-01T13:35:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/connective-tissue-growth-factor-specific-monoclonal-antibody-inhibits-growth-of-malignant-mesothelioma-in-an-orthotopic-mouse-model/ 2018-05-03T13:27:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/antitumor-efficacy-of-kisspeptin-in-human-malignant-mesothelioma-cells/ 2018-05-07T15:43:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-plakophilin-3-in-diffuse-malignant-pleural-mesothelioma/ 2018-05-07T16:30:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-national-practice-patterns-outcomes-and-predictors-of-survival/ 2018-05-07T20:20:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/nintedanib-is-active-in-malignant-pleural-mesothelioma-cell-models-and-inhibits-angiogenesis-and-tumor-growth-in-vivo/ 2018-05-08T13:09:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-innovative-therapeutic-approach-for-malignant-mesothelioma-treatment-based-on-the-use-of-gd-boron-multimodal-probes-for-mri-guided-bnct/ 2018-05-10T15:37:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/facility-volume-and-postoperative-outcomes-for-malignant-pleural-mesothelioma-a-national-cancer-data-base-analysis/ 2018-05-14T16:00:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/loss-of-c-ebp-%ce%b2-lip-drives-cisplatin-resistance-in-malignant-pleural-mesothelioma/ 2018-05-16T13:47:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/revised-modified-recist-criteria-for-assessment-of-response-in-malignant-pleural-mesothelioma-version-1-1/ 2018-05-14T18:10:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-i-trial-of-surgical-resection-and-intraoperative-hyperthermic-cisplatin-and-gemcitabine-for-pleural-mesothelioma/ 2018-05-14T18:19:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-loss-is-unusual-in-well-differentiated-papillary-mesothelioma-and-may-predict-development-of-malignant-mesothelioma/ 2018-05-17T13:24:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/targeting-tie-2-angiopoietin-axis-in-experimental-mesothelioma-confers-differential-responses-and-raises-predictive-implications/ 2018-05-21T13:37:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/tremelimumab-combined-with-durvalumab-in-patients-with-mesothelioma-nibit-meso-1-an-open-label-non-randomised-phase-2-study/ 2018-05-21T13:56:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/how-to-assess-the-best-immunohistochemical-panel-in-the-diagnosis-of-malignant-pleural-mesothelioma-in-a-pathology-lab/ 2018-05-21T15:02:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-subgroup-of-pleural-mesothelioma-expresses-alk-protein-and-may-be-targetable-by-combined-rapamycin-and-crizotinib-therapy/ 2018-05-21T15:41:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/glypican-1-immunohistochemistry-does-not-separate-mesothelioma-from-pulmonary-adenocarcinoma/ 2018-05-24T13:22:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/recurrence-of-pericardial-mesothelioma-affecting-the-myocardium-after-pericardial-resection/ 2018-05-29T12:51:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/longevity-and-pleural-mesothelioma-age-period-cohort-analysis-of-incidence-data-from-the-surveillance-epidemiology-and-end-results-seer-program-1973-2013/ 2018-05-29T13:17:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/four-immunohistochemical-assays-to-measure-the-pd-l1-expression-in-malignant-pleural-mesothelioma/ 2018-05-29T13:17:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/18f-fluorodeoxyglucose-imaging-of-primary-malignant-pericardial-mesothelioma-with-concurrent-pericardial-and-pleural-effusions-and-bone-metastasis-a-case-report/ 2018-05-30T13:06:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/surgical-options-for-malignant-mesothelioma-a-single-center-experience/ 2018-06-04T12:52:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/soluble-cd157-in-pleural-effusions-a-complementary-tool-for-the-diagnosis-of-malignant-mesothelioma/ 2018-06-04T13:01:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/cancer-incidence-in-a-cohort-of-asbestos-exposed-workers-undergoing-health-surveillance/ 2018-06-06T13:16:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunohistochemically-detectable-metallothionein-expression-in-malignant-pleural-mesotheliomas-is-strongly-associated-with-early-failure-to-platin-based-chemotherapy/ 2018-06-06T13:21:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ii-trial-of-first-line-combination-chemotherapy-with-cisplatin-pemetrexed-and-nivolumab-for-unresectable-malignant-pleural-mesothelioma-a-study-protocol/ 2018-06-06T13:21:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/fdg-pet-derived-parameters-as-prognostic-tool-in-progressive-malignant-pleural-mesothelioma-treated-patients/ 2018-06-11T12:14:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/proton-beam-therapy-for-malignant-pleural-mesothelioma/ 2018-06-11T12:25:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-metastases-from-gastrointestinal-cancer/ 2018-06-11T12:36:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/air-in-the-pleural-cavity-enhances-detection-of-pleural-abnormalities-by-ct-scan/ 2018-06-11T12:49:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/aquaporin-1-aqp-1-expression-in-fluoro-edenite-induced-mesothelioma-effusions-an-approach-by-cell-block-procedure/ 2018-06-11T13:13:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/integrated-histogenetic-analysis-reveals-bap1-mutated-epithelioid-mesothelioma-in-a-patient-with-cancer-of-unknown-primary/ 2018-06-18T14:00:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/heat-shock-protein-90-inhibitors-augment-endogenous-wild-type-p53-expression-but-down-regulate-the-adenovirally-induced-expression-by-inhibiting-a-proteasome-activity/ 2018-06-18T14:22:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/inactivation-of-tp53-and-pten-drives-rapid-development-of-pleural-and-peritoneal-malignant-mesotheliomas/ 2018-06-18T14:34:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/pd-1-blockade-with-nivolumab-in-patients-with-recurrent-malignant-pleural-mesothelioma/ 2018-06-18T14:50:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/increased-sensitivity-to-apoptosis-upon-endoplasmic-reticulum-stress-induced-activation-of-the-unfolded-protein-response-in-chemotherapy-resistant-malignant-pleural-mesothelioma/ 2018-06-25T13:10:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/absence-of-calretinin-protein-expression-in-malignant-mesotheliomas-from-asbestos-exposed-nf2-mice-and-mouse-mesothelioma-cell-lines-from-various-mouse-strains/ 2018-06-25T13:38:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/peritoneal-metastases-from-malignant-mesothelioma/ 2018-06-25T14:50:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/assessment-of-new-hdac-inhibitors-for-immunotherapy-of-malignant-pleural-mesothelioma/ 2018-06-28T16:55:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-asbestos-carbon-nanotube-analogy-an-update/ 2018-07-02T14:18:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/measuring-emps-in-the-lung-what-can-be-measured-in-the-lung-asbestiform-minerals-and-cleavage-fragments/ 2018-07-02T15:09:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/5t4-is-associated-with-favorable-outcome-for-mesothelioma-and-a-target-for-antibody-drug-conjugates/ 2018-07-02T15:43:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/pirfenidone-decreases-mesothelioma-cell-proliferation-and-migration-via-inhibition-of-erk-and-akt-and-regulates-mesothelioma-tumor-microenvironment-in-vivo/ 2018-07-05T13:12:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/dynamic-contrast-enhanced-ct-for-the-assessment-of-tumour-response-in-malignant-pleural-mesothelioma-a-pilot-study/ 2018-07-05T13:21:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-combination-chemotherapy-in-peritoneal-mesothelioma-hyperthermic-intraperitoneal-chemotherapy-hipec-the-renape-study/ 2018-07-09T13:21:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/chemo-manipulation-of-tumor-blood-vessels-by-a-metal-based-anticancer-complex-enhances-antitumor-therapy/ 2018-07-09T14:06:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/adenosine-diphosphate-regulates-mmp2-and-mmp9-activity-in-malignant-mesothelioma-cells/ 2018-07-10T12:57:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-diagnosed-at-a-younger-age-is-associated-with-heavier-asbestos-exposure/ 2018-07-10T13:04:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidemiological-surveillance-of-mesothelioma-mortality-in-italy/ 2018-07-11T13:08:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-minimally-invasive-approach-for-peritonectomy-procedures-and-hyperthermic-intraperitoneal-chemotherapy-hipec-in-limited-peritoneal-carcinomatosis-the-american-society-of-peritoneal-surface-malign/ 2018-07-16T14:29:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/detecting-germline-bap1-mutations-in-patients-with-peritoneal-mesothelioma-benefits-to-patient-and-family-members/ 2018-07-16T14:38:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-characteristics-of-asbestos-related-disease-claims-made-to-the-korea-workers-compensation-and-welfare-service-kcomwel-from-2011-to-2015/ 2018-07-18T13:16:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-for-predicting-malignant-pleural-mesothelioma-in-a-mexican-population/ 2018-07-18T16:56:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/matrix-metalloproteinases-polymorphisms-as-baseline-risk-predictors-in-malignant-pleural-mesothelioma/ 2018-07-20T13:25:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/pre-clinical-models-for-malignant-mesothelioma-research-from-chemical-induced-to-patient-derived-cancer-xenografts/ 2018-07-23T12:58:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/imp3-as-a-prognostic-biomarker-in-patients-with-malignant-peritoneal-mesothelioma/ 2018-07-23T13:05:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/4968/ 2018-07-23T13:14:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-bilateral-metachronous-mesothelioma-of-the-tunica-vaginalis/ 2018-07-23T13:21:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-clinical-trial-of-tumorglow-to-identify-residual-disease-during-pleurectomy-and-decortication/ 2018-07-23T13:34:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/dose-dependent-effect-of-red-blood-cells-transfusion-on-perioperative-and-long-term-outcomes-in-peritoneal-surface-malignancies-treated-with-cytoreduction-and-hipec/ 2018-07-30T15:38:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-systematic-review-and-meta-analysis-of-second-line-therapies-for-treatment-of-mesothelioma/ 2018-07-30T21:55:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/utility-of-methylthioadenosine-phosphorylase-compared-with-bap1-immunohistochemistry-and-cdkn2a-and-nf2-fluorescence-in-situ-hybridization-in-separating-reactive-mesothelial-proliferations-from-epith/ 2018-07-31T14:08:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/differential-regulation-of-the-sphere-formation-and-maintenance-of-cancer-initiating-cells-of-malignant-mesothelioma-via-cd44-and-alk4-signaling-pathways/ 2018-08-01T17:28:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-comparison-of-asbestos-fiber-potency-and-elongate-mineral-particle-emp-potency-for-mesothelioma-in-humans/ 2018-08-06T14:50:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-hippo-pathway-provides-novel-insights-into-lung-cancer-and-mesothelioma-treatment/ 2018-08-06T15:01:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-polysome-based-microrna-screen-identifies-mir-24-3p-as-a-novel-pro-migratory-mirna-in-mesothelioma/ 2018-08-06T15:30:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/upcoming-epidemic-of-asbestos-related-malignant-pleural-mesothelioma-in-taiwan-a-prediction-of-incidence-in-the-next-30-years/ 2018-08-06T15:52:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/measurement-of-telomere-length-in-cells-from-pleural-effusion-asbestos-exposure-causes-telomere-shortening-in-pleural-mesothelial-cells/ 2018-08-20T13:28:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-biphasic-type-an-unusual-and-insidious-case-of-rapidly-progressive-small-blue-cell-tumor/ 2018-08-20T13:50:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-mdm2-via-nutlin-3a-a-potential-therapeutic-approach-for-pleural-mesotheliomas-with-mdm2-induced-inactivation-of-wild-type-p53/ 2018-08-20T14:23:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/hypoxia-promotes-acquisition-of-aggressive-phenotypes-in-human-malignant-mesothelioma/ 2018-08-20T14:34:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/first-case-report-of-malignant-peritoneal-mesothelioma-and-oral-verrucous-carcinoma-in-a-patient-with-a-germline-pten-mutation-a-combination-of-extremely-rare-diseases-with-probable-further-implicati/ 2018-08-20T14:48:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-in-an-infant-with-familial-atm-mutations/ 2018-08-27T15:31:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/5-hydroxymethylcytosine-but-not-mtap-methylation-status-can-stratify-malignant-pleural-mesothelioma-based-on-the-lineage-of-origin/ 2018-08-27T15:39:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-treatments-and-trials-in-malignant-pleural-mesothelioma/ 2018-08-27T16:08:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/early-stage-clinical-characterization-of-malignant-pleural-mesothelioma/ 2018-08-30T13:00:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/bamlet-kills-chemotherapy-resistant-mesothelioma-cells-holding-oleic-acid-in-an-activated-cytotoxic-state/ 2018-09-04T13:36:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/ancillary-studies-in-pleural-pericardial-and-peritoneal-effusion-cytology/ 2018-09-04T13:48:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/benign-multicystic-peritoneal-mesothelioma-in-a-male-patient-with-previous-wilms-tumor-a-case-report-and-review-of-the-literature/ 2018-09-04T13:59:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/gemcitabine-synergizes-with-immune-checkpoint-inhibitors-and-overcomes-resistance-in-a-preclinical-model-and-mesothelioma-patients/ 2018-09-04T14:20:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/are-children-more-vulnerable-to-mesothelioma-than-adults-a-comparison-of-mesothelioma-risk-among-children-and-adults-exposed-non-occupationally-to-blue-asbestos-at-wittenoom/ 2018-09-04T14:45:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-mesothelioma-of-the-peritoneum-is-genetically-defined-by-mutually-exclusive-mutations-in-traf7-and-cdc42/ 2018-09-10T15:38:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-malignant-mesothelioma-versus-pleuropulmonary-synovial-sarcoma-a-clinicopathological-study-of-22-cases-with-molecular-analysis-and-survival-data/ 2018-09-10T15:53:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/anesthetic-management-of-pleurectomy-decortication-under-differential-lung-ventilation/ 2018-09-10T16:01:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/zoledronic-acid-in-the-management-of-mesothelioma-a-feasibility-study-zol-a-trial-study-protocol-for-a-randomised-controlled-trial/ 2018-09-10T16:14:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/modification-of-existing-patient-reported-outcome-measures-qualitative-development-of-the-md-anderson-symptom-inventory-for-malignant-pleural-mesothelioma-mdasi-mpm/ 2018-09-17T12:56:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/familial-risk-of-pleural-mesothelioma-increased-drastically-in-certain-occupations-a-nationwide-prospective-cohort-study/ 2018-09-17T13:10:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-the-photon-dose-calculation-accuracy-in-radiation-therapy-of-malignant-pleural-mesothelioma/ 2018-09-17T13:39:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-numb-and-gli1-in-malignant-pleural-mesothelioma-and-their-clinical-significance/ 2018-09-17T13:50:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/role-of-angiopoietins-in-mesothelioma-progression/ 2018-09-24T13:44:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/preclinical-investigation-of-folate-receptor-targeted-nanoparticles-for-photodynamic-therapy-of-malignant-pleural-mesothelioma/ 2018-09-24T14:10:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/survival-by-histologic-subtype-of-malignant-pleural-mesothelioma-and-the-impact-of-surgical-resection-on-overall-survival/ 2018-09-24T14:48:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/intensity-modulated-radiotherapy-is-a-safe-and-effective-treatment-for-localized-malignant-pleural-mesothelioma/ 2018-09-24T14:59:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/mortality-in-a-cohort-of-asbestos-exposed-workers-undergoing-health-surveillance/ 2018-09-24T15:17:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/international-analysis-of-age-specific-mortality-rates-from-mesothelioma-on-the-basis-of-the-international-classification-of-diseases-10th-revision/ 2018-10-01T14:31:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/novel-platinum-agents-and-mesenchymal-stromal-cells-for-thoracic-malignancies-state-of-the-art-and-future-perspectives/ 2018-10-01T14:43:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/autologous-dendritic-cell-therapy-in-mesothelioma-patients-enhances-frequencies-of-peripheral-cd4-t-cells-expressing-hla-dr-pd-1-or-icos/ 2018-10-01T15:13:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/prediagnostic-detection-of-mesothelioma-by-circulating-calretinin-and-mesothelin-a-case-control-comparison-nested-into-a-prospective-cohort-of-asbestos-exposed-workers/ 2018-10-01T15:34:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/moderately-hypofractionated-helical-imrt-fdg-pet-ct-guided-for-progressive-malignant-pleural-mesothelioma-in-patients-with-intact-lungs/ 2018-10-09T12:44:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/whats-new-in-mesothelioma/ 2018-10-08T14:23:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/post-transcriptional-regulation-of-pias3-expression-by-mir-18a-in-malignant-mesothelioma/ 2018-10-08T14:38:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/four-mirna-signature-to-identify-asbestos-related-lung-malignancies/ 2018-10-08T14:53:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/moderately-hypofractionated-helical-imrt-fdg-pet-ct-guided-for-progressive-malignant-pleural-mesothelioma-in-patients-with-intact-lungs-2/ 2018-10-08T15:49:07+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-efforts-in-research-of-pleural-mesothelioma-an-analysis-of-the-clinicaltrials-gov-registry/ 2018-10-08T16:20:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/is-there-a-role-for-cancer-directed-surgery-in-early-stage-sarcomatoid-or-biphasic-mesothelioma/ 2018-10-15T16:05:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/combination-immune-checkpoint-blockade-as-an-effective-therapy-for-mesothelioma/ 2018-10-15T16:21:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/short-term-outcomes-of-pleurectomy-decortication-and-extrapleural-pneumonectomy-in-mesothelioma/ 2018-10-15T16:45:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-and-pathological-profile-of-the-pleural-malignant-mesothelioma-a-retrospective-study-about-30-cases/ 2018-10-15T17:16:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/postoperative-complications-independently-predict-cancer-related-survival-in-peritoneal-malignancies/ 2018-10-15T17:28:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/neoantigenic-potential-of-complex-chromosomal-rearrangements-in-mesothelioma/ 2018-10-22T16:20:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibiting-crosstalk-between-met-signaling-and-mitochondrial-dynamics-and-morphology-a-novel-therapeutic-approach-for-lung-cancer-and-mesothelioma/ 2018-10-22T16:57:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/brain-derived-neurotrophic-factor-a-new-soluble-biomarker-for-malignant-pleural-mesothelioma-involved-in-angiogenesis/ 2018-10-22T18:09:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibiting-crosstalk-between-met-signaling-and-mitochondrial-dynamics-and-morphology-a-novel-therapeutic-approach-for-lung-cancer-and-mesothelioma-2/ 2018-10-22T18:21:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/brain-derived-neurotrophic-factor-a-new-soluble-biomarker-for-malignant-pleural-mesothelioma-involved-in-angiogenesis-2/ 2018-10-22T18:29:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnosis-of-malignant-pleural-mesothelioma-from-pleural-fluid-by-fourier-transform-infrared-spectroscopy-coupled-with-chemometrics/ 2018-10-29T14:35:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-the-role-of-surgery/ 2018-10-29T15:04:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/muc21-is-a-novel-negative-immunohistochemical-marker-for-epithelioid-mesothelioma-for-its-differentiation-from-lung-adenocarcinoma/ 2018-10-29T15:30:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/sensitivity-to-asbestos-is-increased-in-patients-with-mesothelioma-and-pathogenic-germline-variants-in-bap1-or-other-dna-repair-genes/ 2018-10-29T15:49:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/transglutaminase-is-a-mesothelioma-cancer-stem-cell-survival-protein-that-is-required-for-tumor-formation/ 2018-10-29T16:05:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/luminol-chemiluminescence-reports-photodynamic-therapy-generated-neutrophil-activity-in-vivo-and-serves-as-a-biomarker-of-therapeutic-efficacy/ 2018-11-05T14:29:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/prediction-modelling-using-routine-clinical-parameters-to-stratify-survival-in-malignant-pleural-mesothelioma-patients-undergoing-cytoreductive-surgery/ 2018-11-05T15:27:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-of-tunica-vaginalis-testis-report-of-a-very-rare-case-with-review-of-the-literature/ 2018-11-05T16:40:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-significance-of-serum-dram1-mrna-arsa-mrna-hsa-mir-2053-and-lncrna-rp1-86d1-3-axis-expression-in-malignant-pleural-mesothelioma/ 2018-11-05T17:02:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/experimental-study-of-the-inhibition-effect-of-cxcl12-cxcr4-in-malignant-pleural-mesothelioma/ 2018-11-05T17:18:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-subset-of-mesotheliomas-with-improved-survival-occurring-in-carriers-of-bap1-and-other-germline-mutations/ 2018-11-12T14:27:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/updated-meta-analysis-of-survival-after-extrapleural-pneumonectomy-versus-pleurectomy-decortication-in-mesothelioma/ 2018-11-12T18:11:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-fiber-type-and-cumulative-exposure-in-controlling-mesothelioma-risk/ 2018-11-12T19:38:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-clinical-aspects-and-therapeutic-perspectives/ 2018-11-12T19:53:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/differential-survival-characteristics-of-sarcomatoid-subtype-biphasic-pleural-mesothelioma/ 2018-11-12T20:09:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/taz-activation-by-hippo-pathway-dysregulation-induces-cytokine-gene-expression-and-promotes-mesothelial-cell-transformation/ 2018-11-19T14:42:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/peripheral-blood-dna-methylation-as-potential-biomarker-of-malignant-pleural-mesothelioma-in-asbestos-exposed-subjects/ 2018-11-19T14:56:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/apatinib-for-salvage-treatment-of-advanced-malignant-pleural-mesothelioma-a-case-report/ 2018-11-19T15:03:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/factors-influencing-malignant-mesothelioma-survival-a-retrospective-review-of-the-national-mesothelioma-virtual-bank-cohort/ 2018-11-19T15:28:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/multimodality-treatment-of-malignant-pleural-mesothelioma/ 2018-11-19T15:40:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-mesothelioma-a-17-year-single-institution-experience-with-a-series-of-75-cases/ 2018-11-26T14:57:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/decrease-in-intracellular-perforin-levels-and-ifn-%ce%b3-production-in-human-cd8-t-cell-line-following-long-term-exposure-to-asbestos-fibers/ 2018-11-26T15:57:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/pyruvate-treatment-restores-the-effectiveness-of-chemotherapeutic-agents-in-human-colon-adenocarcinoma-and-pleural-mesothelioma-cells/ 2018-11-26T16:38:20+00:00 monthly 0.2 https://www.mesothelioma-line.com/real-life-treatment-practice-for-malignant-pleural-mesothelioma-in-belgium/ 2018-11-26T17:16:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-combination-of-mtap-and-bap1-immunohistochemistry-is-effective-for-distinguishing-sarcomatoid-mesothelioma-from-fibrous-pleuritis/ 2018-11-26T17:41:11+00:00 monthly 0.2 https://www.mesothelioma-line.com/update-on-the-management-of-malignant-peritoneal-mesothelioma/ 2018-12-03T15:10:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-randomized-phase-ii-study-of-pleurectomy-decortication-preceded-or-followed-by-neo-adjuvant-chemotherapy-in-patients-with-early-stage-malignant-pleural-mesothelioma-eortc-1205/ 2018-12-03T15:16:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/is-there-a-role-for-prophylactic-radiotherapy-to-intervention-tract-sites-in-patients-with-malignant-pleural-mesothelioma/ 2018-12-03T15:24:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-of-malignant-pleural-mesothelioma-with-chemotherapy-preceding-versus-after-surgical-resection/ 2018-12-03T15:39:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/effect-of-the-bh3-mimetic-polyphenol-gossypol-at-101-on-the-in-vitro-and-in-vivo-growth-of-malignant-mesothelioma/ 2018-12-03T16:04:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-peritoneal-mesothelioma-treated-by-cytoreduction-and-hyperthermic-intraperitoneal-chemotherapy-the-experience-of-the-psogi-registry/ 2018-12-07T18:41:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-significance-of-non-occupational-asbestos-exposure-in-women-with-mesothelioma/ 2018-12-07T18:46:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/primary-malignant-deciduoid-mesothelioma-a-challenging-diagnosis/ 2018-12-07T19:46:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/detection-of-circulating-tumor-cells-with-a-novel-microfluidic-system-in-malignant-pleural-mesothelioma/ 2018-12-07T19:51:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/systematic-review-of-quality-of-life-following-pleurectomy-decortication-and-extrapleural-pneumonectomy-for-malignant-pleural-mesothelioma/ 2018-12-07T19:56:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-exposure-and-mesothelioma-mortality-among-atomic-veterans/ 2018-12-17T14:19:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/complex-immune-contextures-characterise-malignant-peritoneal-mesothelioma-loss-of-adaptive-immunological-signature-in-the-more-aggressive-histological-types/ 2018-12-17T14:49:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-of-database-european-society-of-thoracic-surgeons-mesothelioma-database-difficulties-in-improving-quality-data-for-rare-tumour/ 2018-12-17T15:25:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-brca1-associated-protein-1-in-the-diagnosis-of-malignant-mesothelioma-in-effusion-and-fine-needle-aspiration-cytology/ 2018-12-17T15:55:00+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumour-associated-lymphocytes-in-the-pleural-effusions-of-patients-with-mesothelioma-express-high-levels-of-inhibitory-receptors/ 2018-12-17T16:09:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/biodistribution-and-tumor-uptake-of-67ga-nimotuzumab-in-a-malignant-pleural-mesothelioma-xenograft/ 2018-12-17T16:26:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-regulatory-status-adopted-by-lymph-node-dendritic-cells-and-t-cells-during-healthy-aging-is-maintained-during-cancer-and-may-contribute-to-reduced-responses-to-immunotherapy/ 2019-01-02T15:41:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleural-thickness-after-neoadjuvant-chemotherapy-is-a-prognostic-factor-in-malignant-pleural-mesothelioma/ 2019-01-02T16:03:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-effect-of-rapid-infusion-of-cisplatin-on-nephrotoxicity-in-patients-with-lung-carcinoma/ 2019-01-02T16:43:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/splicing-modulation-as-novel-therapeutic-strategy-against-diffuse-malignant-peritoneal-mesothelioma/ 2019-01-07T16:46:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/treatment-and-outcomes-of-primary-pericardial-mesothelioma-a-contemporary-review-of-103-published-cases/ 2019-01-07T17:16:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/immunotherapy-strategies-for-mesothelioma-the-role-of-tumor-specific-neoantigens-in-a-new-era-of-precision-medicine/ 2019-01-07T17:38:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/association-between-mesothelioma-and-non-occupational-asbestos-exposure-systematic-review-and-meta-analysis/ 2019-01-07T17:55:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-mesothelioma-a-histomorphological-and-immunohistochemical-study-of-24-cases-from-a-tertiary-care-hospital-in-southern-india/ 2019-01-07T18:14:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/factors-influencing-malignant-mesothelioma-survival-a-retrospective-review-of-the-national-mesothelioma-virtual-bank-cohort-2/ 2019-01-14T14:46:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/epithelial-to-mesenchymal-transition-in-human-mesothelial-cells-exposed-to-asbestos-fibers-role-of-tgf-%ce%b2-as-mediator-of-malignant-mesothelioma-development-or-metastasis-via-emt-event/ 2019-01-14T15:02:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/population-based-cohort-study-on-health-effects-of-asbestos-exposure-in-japan/ 2019-01-14T15:16:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/correlation-of-patient-survival-with-clinical-tumor-measurements-in-malignant-pleural-mesothelioma/ 2019-01-14T15:46:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/micrornas-for-the-diagnosis-and-management-of-malignant-pleural-mesothelioma-a-literature-review/ 2019-01-14T15:54:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/computational-prediction-of-diagnosis-and-feature-selection-on-mesothelioma-patient-health-records/ 2019-01-21T15:14:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/heparanase-inhibitors-restrain-mesothelioma/ 2019-01-21T16:12:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/well-differentiated-papillary-mesothelioma-of-the-peritoneum-a-retrospective-study-from-the-renape-observational-registry/ 2019-01-21T16:01:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-pathways-and-diagnosis-in-malignant-mesothelioma-a-review-of-the-14th-international-conference-of-the-international-mesothelioma-interest-group/ 2019-01-21T16:11:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/retrospective-response-analysis-of-bap1-expression-to-predict-the-clinical-activity-of-systemic-cytotoxic-chemotherapy-in-mesothelioma/ 2019-01-21T17:01:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/dosimetric-correlates-of-pulmonary-toxicity-in-patients-with-malignant-pleural-mesothelioma-receiving-radiation-therapy-to-the-intact-lungs/ 2019-01-28T14:47:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelin-targeted-second-generation-car-t-cells-inhibit-growth-of-mesothelin-expressing-tumors-in-vivo/ 2019-01-28T19:29:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/adam10-mediates-malignant-pleural-mesothelioma-invasiveness/ 2019-01-28T19:36:15+00:00 monthly 0.2 https://www.mesothelioma-line.com/prognostic-factors-of-survival-in-patients-with-malignant-pleural-mesothelioma-an-analysis-of-the-national-cancer-data-base/ 2019-01-28T19:44:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/antagonists-of-growth-hormone-releasing-hormone-ghrh-inhibit-the-growth-of-human-malignant-pleural-mesothelioma/ 2019-01-28T19:56:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/progress-of-malignant-mesothelioma-research-in-basic-science-a-review-of-the-14th-international-conference-of-the-international-mesothelioma-interest-group-imig2018/ 2019-02-04T16:15:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/early-specialist-palliative-care-on-quality-of-life-for-malignant-pleural-mesothelioma-a-randomised-controlled-trial/ 2019-02-04T15:02:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-loss-is-a-useful-adjunct-to-distinguish-malignant-mesothelioma-including-the-adenomatoid-like-variant-from-benign-adenomatoid-tumors/ 2019-02-04T16:14:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/pretreatment-controlling-nutritional-status-score-and-lactate-dehydrogenase-as-predictive-markers-of-survival-in-patients-with-malignant-peritoneal-mesothelioma/ 2019-02-04T16:26:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-status-determines-the-sensitivity-of-malignant-mesothelioma-cells-to-gemcitabine-treatment/ 2019-02-04T16:52:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/inhibition-of-collagen-production-delays-malignant-mesothelioma-tumor-growth-in-a-murine-model/ 2019-02-11T14:53:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/computed-tomography-features-of-local-pleural-recurrence-in-patients-with-malignant-pleural-mesothelioma-treated-with-intensity-modulated-pleural-radiation-therapy/ 2019-02-11T18:31:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-of-asbestos-on-public-health-a-retrospective-study-on-a-series-of-subjects-with-occupational-and-non-occupational-exposure-to-asbestos-during-the-activity-of-fibronit-plant-broni-italy/ 2019-02-11T19:26:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesotrap-a-feasibility-study-that-includes-a-pilot-clinical-trial-comparing-video-assisted-thoracoscopic-partial-pleurectomy-decortication-with-indwelling-pleural-catheter-in-patients-with-trapped-lu/ 2019-02-11T19:35:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/gene-expression-profiling-of-homologous-recombination-repair-pathway-indicates-susceptibility-for-olaparib-treatment-in-malignant-pleural-mesothelioma-in-vitro/ 2019-02-11T20:06:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/versican-modulates-tumor-associated-macrophage-properties-to-stimulate-mesothelioma-growth/ 2019-02-18T14:39:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-peritoneal-mesothelioma-treatment-options-and-survival/ 2019-02-18T14:54:22+00:00 monthly 0.2 https://www.mesothelioma-line.com/tenascin-xb-is-a-novel-diagnostic-marker-for-malignant-mesothelioma/ 2019-02-18T15:07:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/fluorodeoxyglucose-versus-choline-positron-emission-tomography-computed-tomography-response-evaluation-in-two-malignant-pleural-mesothelioma-patients-treated-with-talc-pleurodesis-and-neoadjuvant-chem/ 2019-02-18T15:28:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/mst1-hippo-promoter-gene-methylation-predicts-poor-survival-in-patients-with-malignant-pleural-mesothelioma-in-the-ifct-gfpc-0701-maps-phase-3-trial/ 2019-02-18T16:13:24+00:00 monthly 0.2 https://www.mesothelioma-line.com/current-status-of-cytoreductive-surgery-crs-and-intraperitoneal-hyperthermic-chemotherapy-hipec-in-the-multimodal-treatment-of-peritoneal-surface-malignancies/ 2019-02-25T15:29:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestosis-and-silicosis-hospitalizations-in-italy-2001-2015-results-from-the-national-hospital-discharge-registry/ 2019-02-25T15:54:56+00:00 monthly 0.2 https://www.mesothelioma-line.com/are-circulating-micrornas-suitable-for-the-early-detection-of-malignant-mesothelioma-results-from-a-nested-case-control-study/ 2019-02-25T16:22:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/use-of-immune-checkpoint-inhibitors-in-mesothelioma/ 2019-02-25T16:45:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/pemetrexed-loaded-nanoparticles-targeted-to-malignant-pleural-mesothelioma-cells-an-in-vitro-study/ 2019-02-25T17:14:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/maintenance-defactinib-versus-placebo-after-first-line-chemotherapy-in-patients-with-merlin-stratified-pleural-mesothelioma-command-a-double-blind-randomized-phase-ii-study/ 2019-03-04T15:23:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/vascular-targeted-low-dose-photodynamic-therapy-stabilizes-tumor-vessels-by-modulating-pericyte-contractility/ 2019-03-04T16:15:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/bap1-haploinsufficiency-predicts-a-distinct-immunogenic-class-of-malignant-peritoneal-mesothelioma/ 2019-03-04T16:52:13+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumor-pd-l1-expression-in-malignant-pleural-and-peritoneal-mesothelioma-by-dako-pd-l1-22c3-pharmdx-and-dako-pd-l1-28-8-pharmdx-assays/ 2019-03-04T17:07:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/malignant-pleural-mesothelioma-is-tailoring-the-second-line-therapy-really-raising-the-bar/ 2019-03-04T17:29:28+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-adjuvant-radiotherapy-in-the-treatment-of-pleural-mesothelioma/ 2019-03-11T13:55:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/environmental-asbestos-exposure-in-childhood-and-risk-of-mesothelioma-later-in-life-a-long-term-follow-up-register-based-cohort-study/ 2019-03-12T15:24:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinicopathological-characteristics-of-well-differentiated-papillary-mesothelioma-of-the-peritoneum-a-single-institutional-experience-of-12-cases/ 2019-03-13T13:38:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/therapeutic-efficacy-evaluation-of-radioimmunotherapy-with-90-y-labeled-anti-podoplanin-antibody-nz-12-for-mesothelioma/ 2019-03-13T13:48:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/about-the-diagnostic-value-of-bap-1-antibody-in-malignant-pleural-mesothelioma-a-meta-analysis/ 2019-03-13T13:59:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/development-and-validation-of-a-prognostic-signature-for-malignant-pleural-mesothelioma/ 2019-03-19T16:02:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/genetic-polymorphisms-in-aquaporin-1-as-risk-factors-for-malignant-mesothelioma-and-biomarkers-of-response-to-cisplatin-treatment/ 2019-03-19T16:09:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/tumour-infiltrating-lymphocytes-and-pd-l1-expression-as-potential-predictors-of-outcome-in-patients-with-malignant-pleural-mesothelioma/ 2019-03-19T16:23:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/significance-of-egfr-and-pten-expression-and-plr-and-nlr-for-predicting-the-prognosis-of-epithelioid-malignant-peritoneal-mesothelioma/ 2019-03-19T17:05:04+00:00 monthly 0.2 https://www.mesothelioma-line.com/prolonged-post-recurrence-survival-following-pleurectomy-decortication-for-malignant-pleural-mesothelioma/ 2019-03-25T13:48:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-toxicology-of-chrysotile-containing-brake-debris-implications-for-mesothelioma/ 2019-03-25T17:54:12+00:00 monthly 0.2 https://www.mesothelioma-line.com/exposure-response-analysis-of-overall-survival-for-tremelimumab-in-unresectable-malignant-mesothelioma-the-confounding-effect-of-disease-status/ 2019-03-25T19:10:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/cryobiopsy-during-flex-rigid-pleuroscopy-an-emerging-alternative-biopsy-method-in-malignant-pleural-mesothelioma-a-comparative-study-of-pathology/ 2019-03-25T19:24:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/localized-multiple-malignant-epithelioid-peritoneal-mesotheliomas-arising-from-the-hepatoduodenal-ligament-and-diaphragm-a-case-report/ 2019-03-25T19:42:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/in-commemoration-of-the-2018-mataro-nagayo-prize-a-road-to-early-diagnosis-and-monitoring-of-asbestos-related-mesothelioma/ 2019-04-01T13:54:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/hyperthermic-intrathoracic-chemotherapy-hithoc-for-pleural-malignancies-experience-from-indian-centers/ 2019-04-01T14:56:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/body-composition-and-nutritional-status-in-malignant-pleural-mesothelioma-implications-for-activity-levels-and-quality-of-life/ 2019-04-01T15:49:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/making-cold-malignant-pleural-effusions-hot-driving-novel-immunotherapies/ 2019-04-01T16:01:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/dissecting-heterogeneity-in-malignant-pleural-mesothelioma-through-histo-molecular-gradients-for-clinical-applications/ 2019-04-01T16:17:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/epidermal-growth-factor-receptor-egfr-targeted-therapies-in-mesothelioma/ 2019-04-08T14:48:05+00:00 monthly 0.2 https://www.mesothelioma-line.com/asbestos-fiber-identification-in-liver-from-cholangiocarcinoma-patients-living-in-an-asbestos-polluted-area-a-preliminary-study/ 2019-04-08T15:13:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/tomotherapy-in-malignant-mesothelioma-a-planning-study-to-establish-dose-constraints/ 2019-04-08T15:53:55+00:00 monthly 0.2 https://www.mesothelioma-line.com/prophylactic-irradiation-of-tracts-in-patients-with-malignant-pleural-mesothelioma-an-open-label-multicenter-phase-iii-randomized-trial/ 2019-04-08T16:34:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/patterns-of-care-and-survival-of-older-patients-with-malignant-pleural-mesothelioma/ 2019-04-08T17:04:17+00:00 monthly 0.2 https://www.mesothelioma-line.com/bilateral-diffuse-pulmonary-infiltrates-secondary-to-malignant-peritoneal-mesothelioma-a-rare-clinical-presentation/ 2019-04-15T14:14:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-case-from-india-of-pleural-malignant-mesothelioma-probably-due-to-domestic-and-environmental-asbestos-exposure-a-posthumous-report/ 2019-04-15T15:00:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/droplet-digital-pcr-as-a-novel-system-for-the-detection-of-microrna%e2%80%9134b-c-methylation-in-circulating-dna-in-malignant-pleural-mesothelioma/ 2019-04-15T15:21:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-investigation-of-lipoxygenases-as-therapeutic-targets-in-malignant-pleural-mesothelioma/ 2019-04-15T15:46:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/ten-year-experience-with-peritoneal-mesothelioma/ 2019-04-15T16:12:47+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-delphi-and-grade-methodology-used-in-the-psogi-2018-consensus-statement-on-pseudomyxoma-peritonei-and-peritoneal-mesothelioma/ 2019-04-22T14:49:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/benign-pleural-mesothelial-cells-have-higher-osmotic-water-permeability-than-malignant-pleural-mesothelioma-cells-and-differentially-respond-to-hyperosmolality/ 2019-04-22T15:18:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/cytoplasmic-mtap-expression-loss-detected-by-immunohistochemistry-correlates-with-9p21-homozygous-deletion-detected-by-fish-in-pleural-effusion-cytology-of-mesothelioma/ 2019-04-22T15:57:31+00:00 monthly 0.2 https://www.mesothelioma-line.com/extra-pleural-pneumonectomy-in-the-era-of-image-guided-intensity-modulated-radiotherapy/ 2019-04-22T16:39:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-mediastinal-lymph-node-staging-in-malignant-pleural-mesothelioma/ 2019-04-22T17:10:36+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-2-open-label-study-of-brentuximab-vedotin-in-patients-with-cd30-expressing-solid-tumors/ 2019-04-29T14:49:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/risk-of-mesothelioma-after-cessation-of-asbestos-exposure-a-systematic-review-and-meta-regression/ 2019-04-29T15:13:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/chemotherapy-versus-supportive-care-for-unresected-malignant-pleural-mesothelioma/ 2019-04-29T15:31:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/management-of-malignant-pleural-mesothelioma-in-the-elderly-population/ 2019-04-29T16:05:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/nk-and-t-cell-subsets-in-malignant-mesothelioma-patients-baseline-pattern-and-changes-in-the-context-of-anti-ctla-4-therapy/ 2019-04-29T16:19:21+00:00 monthly 0.2 https://www.mesothelioma-line.com/synthetic-secoisolariciresinol-diglucoside-lgm2605-inhibits-libby-amphibole-fiber-induced-acute-inflammation-in-mice/ 2019-05-06T14:06:18+00:00 monthly 0.2 https://www.mesothelioma-line.com/extra-pleural-pneumonectomy/ 2019-05-06T14:27:46+00:00 monthly 0.2 https://www.mesothelioma-line.com/pathological-evaluation-of-the-visceral-pleura-in-the-radical-pleurectomy-decortication-for-malignant-pleural-mesothelioma-patients/ 2019-05-06T14:42:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-accuracy-of-a-limited-immuno-panel-of-calretinin-and-ber-ep4-for-diagnosis-of-malignant-effusions/ 2019-05-06T15:01:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/ampk-activation-induced-in-pemetrexed-treated-cells-is-associated-with-development-of-drug-resistance-independently-of-target-enzyme-expression/ 2019-05-06T15:20:43+00:00 monthly 0.2 https://www.mesothelioma-line.com/immune-checkpoint-inhibition-for-the-treatment-of-mesothelioma/ 2019-05-13T14:50:16+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-frequency-and-severity-of-pleural-changes-in-former-workers-exposed-to-anthophyllite-associated-with-other-contaminating-amphibole-asbestos-in-brazil/ 2019-05-13T15:18:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/first-ever-abscopal-effect-after-palliative-radiotherapy-and-immuno-gene-therapy-for-malignant-pleural-mesothelioma/ 2019-05-13T15:35:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/impact-on-survival-of-nuclear-atypia-in-epithelioid-malignant-mesothelioma/ 2019-05-13T15:57:49+00:00 monthly 0.2 https://www.mesothelioma-line.com/whole-genome-sequencing-of-human-malignant-mesothelioma-tumours-and-cell-lines/ 2019-05-13T16:09:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/50-patients-with-malignant-mesothelioma-of-both-the-pleura-and-peritoneum-a-single-institution-experience/ 2019-05-20T14:10:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-phase-ib-study-of-gsk3052230-an-fgf-ligand-trap-in-combination-with-pemetrexed-and-cisplatin-in-patients-with-malignant-pleural-mesothelioma/ 2019-05-20T14:42:41+00:00 monthly 0.2 https://www.mesothelioma-line.com/effect-of-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-on-quality-of-life-in-patients-with-peritoneal-mesothelioma/ 2019-05-20T15:22:14+00:00 monthly 0.2 https://www.mesothelioma-line.com/confocal-laser-endomicroscopy-cle-as-a-guidance-tool-for-pleural-biopsies-in-malignant-pleural-mesothelioma/ 2019-05-20T15:48:30+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelin-targeted-thorium-227-conjugate-msln-ttc-preclinical-evaluation-of-a-new-targeted-alpha-therapy-for-mesothelin-positive-cancers/ 2019-05-20T16:16:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/quantitative-relationships-of-exposure-to-chrysotile-asbestos-and-mesothelioma-mortality/ 2019-05-28T15:36:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/loco-regional-staging-of-malignant-pleural-mesothelioma-by-integrated-18f-fdg-pet-mri/ 2019-05-28T16:07:01+00:00 monthly 0.2 https://www.mesothelioma-line.com/adjuvant-dendritic-cell-based-immunotherapy-dcbi-after-cytoreductive-surgery-crs-and-hyperthermic-intraperitoneal-chemotherapy-hipec-for-peritoneal-mesothelioma-a-phase-ii-single-centre-open-la/ 2019-05-28T16:34:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/nintedanib-in-combination-with-pemetrexed-and-cisplatin-for-chemotherapy-naive-patients-with-advanced-malignant-pleural-mesothelioma-lume-meso-a-double-blind-randomised-placebo-controlled-phase-3/ 2019-06-03T13:55:26+00:00 monthly 0.2 https://www.mesothelioma-line.com/wnt-il-1%ce%b2-il-8-autocrine-circuitries-control-chemoresistance-in-mesothelioma-initiating-cells-by-inducing-abcb5/ 2019-06-03T20:30:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/validation-of-an-asbestos-job-exposure-matrix-asbjem-in-australia-exposure-response-relationships-for-malignant-mesothelioma/ 2019-06-03T20:39:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-role-of-apoptosis-defects-in-malignant-mesothelioma-pathogenesis-with-an-impact-on-prognosis-and-treatment/ 2019-06-03T20:50:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/high-systemic-immune-inflammation-index-represents-an-unfavorable-prognosis-of-malignant-pleural-mesothelioma/ 2019-06-03T20:56:58+00:00 monthly 0.2 https://www.mesothelioma-line.com/cdkn2a-copy-number-and-p16-expression-in-malignant-pleural-mesothelioma-in-relation-to-asbestos-exposure/ 2019-06-10T15:14:40+00:00 monthly 0.2 https://www.mesothelioma-line.com/signet-ring-cell-mesothelioma-a-diagnostic-challenge/ 2019-06-10T16:01:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-redox-inactive-derivative-of-tocotrienol-suppresses-tumor-growth-of-mesothelioma-cells-in-a-xenograft-model/ 2019-06-10T16:11:42+00:00 monthly 0.2 https://www.mesothelioma-line.com/inactivation-of-bap1-cooperates-with-losses-of-nf2-and-cdkn2a-to-drive-the-development-of-pleural-malignant-mesothelioma-in-conditional-mouse-models/ 2019-06-10T16:47:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/diagnostic-value-of-bap1-glut-1-and-desmin-expression-in-the-discrimination-between-reactive-mesothelial-proliferation-and-malignant-mesothelioma-in-tissues-and-effusions/ 2019-06-10T17:12:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/clinical-efficacy-and-safety-of-nivolumab-results-of-a-multicenter-open-label-single-arm-japanese-phase-2-study-in-malignant-pleural-mesothelioma-merit/ 2019-06-17T15:12:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-for-malignant-pleural-mesothelioma-a-meta-analysis/ 2019-06-17T15:36:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/health-related-quality-of-life-impact-from-adding-bevacizumab-to-cisplatin-pemetrexed-in-malignant-pleural-mesothelioma-in-the-maps-ifct-gfpc-0701-phase-iii-trial/ 2019-06-17T15:48:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/expression-of-estrogen-receptor-beta-er%ce%b2-and-its-prognostic-value-in-pleural-mesothelioma/ 2019-06-17T16:27:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/defining-the-role-of-adjuvant-radiotherapy-for-malignant-pleural-mesothelioma-a-propensity-matched-landmark-analysis-of-the-national-cancer-database/ 2019-06-17T16:51:57+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-prevalence-and-clinical-relevance-of-non-expandable-lung-in-malignant-pleural-mesothelioma-a-prospective-single-center-cohort-study-of-229-patients/ 2019-06-24T16:48:25+00:00 monthly 0.2 https://www.mesothelioma-line.com/biomarkers-for-detecting-malignant-pleural-mesothelioma-protocol-for-a-reanalysis-of-published-data-based-on-systematic-reviews-of-diagnostic-test-accuracy/ 2019-06-24T16:56:53+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-matrix-metalloproteinase-9-serum-concentration-as-a-biomarker-in-malignant-mesothelioma/ 2019-06-24T17:03:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/baseline-predictors-of-negative-and-incomplete-pleural-cytology-in-patients-with-suspected-pleural-malignancy-data-supporting-direct-to-lat-in-selected-groups/ 2019-06-24T17:25:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/does-simian-virus-40-sv40-have-a-role-in-uk-malignant-pleural-mesothelioma-no-role-is-identified-in-a-sensitive-rna-in-situ-hybridization-study-on-potentially-affected-birth-cohorts/ 2019-06-24T17:35:33+00:00 monthly 0.2 https://www.mesothelioma-line.com/autophagy-facilitates-the-release-of-immunogenic-signals-following-chemotherapy-in-3d-models-of-mesothelioma/ 2019-07-01T15:05:08+00:00 monthly 0.2 https://www.mesothelioma-line.com/mir-625-3p-and-lncrna-gas5-in-liquid-biopsies-for-predicting-the-outcome-of-malignant-pleural-mesothelioma-patients-treated-with-neo-adjuvant-chemotherapy-and-surgery/ 2019-07-01T15:24:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/in-silico-transcriptomic-analysis-of-wound-healing-associated-genes-in-malignant-pleural-mesothelioma/ 2019-07-01T15:50:34+00:00 monthly 0.2 https://www.mesothelioma-line.com/evaluation-of-the-psychometric-properties-and-minimally-important-difference-of-the-md-anderson-symptom-inventory-for-malignant-pleural-mesothelioma-mdasi-mpm/ 2019-07-01T16:09:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/breath-analysis-a-systematic-review-of-volatile-organic-compounds-vocs-in-diagnostic-and-therapeutic-management-of-pleural-mesothelioma/ 2019-07-01T16:19:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-asbestos-contaminated-town-in-the-vicinity-of-an-asbestos-cement-facility-the-case-study-of-sibate-colombia/ 2019-07-08T15:03:35+00:00 monthly 0.2 https://www.mesothelioma-line.com/analyzing-biological-and-molecular-characteristics-and-genomic-damage-induced-by-exposure-to-asbestos/ 2019-07-08T15:29:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/hemizygous-loss-of-nf2-detected-by-fluorescence-in-situ-hybridization-is-useful-for-the-diagnosis-of-malignant-pleural-mesothelioma/ 2019-07-08T15:59:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/mtap-immunohistochemistry-is-an-accurate-and-reproducible-surrogate-for-cdkn2a-fluorescence-in-situ-hybridization-in-diagnosis-of-malignant-pleural-mesothelioma/ 2019-07-08T16:33:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/synergistic-enhancement-of-cellular-uptake-with-cd44-expressing-malignant-pleural-mesothelioma-by-combining-cationic-liposome-and-hyaluronic-acid-lipid-conjugate/ 2019-07-08T16:57:38+00:00 monthly 0.2 https://www.mesothelioma-line.com/long-term-survival-and-perioperative-propensity-score-matched-outcomes-of-diaphragmatic-resections-compared-to-stripping-in-cytoreductive-surgery-intra-peritoneal-chemotherapy/ 2019-07-15T15:00:23+00:00 monthly 0.2 https://www.mesothelioma-line.com/2-deoxy-glucose-enhances-the-effect-of-cisplatin-and-pemetrexed-in-reducing-malignant-pleural-mesothelioma-cell-proliferation-but-not-spheroid-growth/ 2019-07-15T16:19:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/live-attenuated-listeria-monocytogenes-expressing-mesothelin-crs-207-with-chemotherapy-for-treatment-of-malignant-pleural-mesothelioma/ 2019-07-15T15:59:50+00:00 monthly 0.2 https://www.mesothelioma-line.com/what-can-independent-research-for-mesothelioma-achieve-to-treat-this-orphan-disease/ 2019-07-15T16:30:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelin-calretinin-and-megakaryocyte-potentiating-factor-as-biomarkers-of-malignant-pleural-mesothelioma/ 2019-07-15T16:40:45+00:00 monthly 0.2 https://www.mesothelioma-line.com/shorter-survival-in-malignant-pleural-mesothelioma-patients-with-high-pd-l1-expression-associated-with-sarcomatoid-or-biphasic-histology-subtype-a-series-of-214-cases-from-the-bio-maps-cohort/ 2019-07-22T14:47:51+00:00 monthly 0.2 https://www.mesothelioma-line.com/efficacy-and-safety-of-pemetrexed-plus-cisplatin-as-first-line-chemotherapy-in-advanced-malignant-peritoneal-mesothelioma/ 2019-07-22T15:05:27+00:00 monthly 0.2 https://www.mesothelioma-line.com/pleurectomy-decortication-and-hyperthermic-intrathoracic-chemoperfusion-using-cisplatin-and-doxorubicin-for-malignant-pleural-mesothelioma/ 2019-07-22T15:40:32+00:00 monthly 0.2 https://www.mesothelioma-line.com/mesothelioma-scientific-clues-for-prevention-diagnosis-and-therapy/ 2019-07-22T16:20:54+00:00 monthly 0.2 https://www.mesothelioma-line.com/pemetrexed-conjugated-hyaluronan-for-the-treatment-of-malignant-pleural-mesothelioma/ 2019-07-22T16:49:52+00:00 monthly 0.2 https://www.mesothelioma-line.com/empirical-model-of-mesothelioma-potency-factors-for-different-mineral-fibers-based-on-their-chemical-composition-and-dimensionality/ 2019-08-06T14:46:39+00:00 monthly 0.2 https://www.mesothelioma-line.com/environmental-and-occupational-exposure-to-asbestos-as-a-result-of-consumption-and-use-in-poland/ 2019-08-06T15:03:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/association-of-two-brm-promoter-polymorphisms-and-smoking-status-with-malignant-pleural-mesothelioma-risk-and-prognosis/ 2019-08-06T15:13:03+00:00 monthly 0.2 https://www.mesothelioma-line.com/the-oncolytic-virus-dl922-947-triggers-immunogenic-cell-death-in-mesothelioma-and-reduces-xenograft-growth/ 2019-08-06T15:45:59+00:00 monthly 0.2 https://www.mesothelioma-line.com/perioperative-anesthetic-management-of-patients-with-malignant-pleural-mesothelioma-undergoing-cytoreductive-surgery-and-intraoperative-chemotherapy/ 2019-08-06T16:01:09+00:00 monthly 0.2 https://www.mesothelioma-line.com/a-multicenter-randomized-phase-ii-iii-study-of-dendritic-cells-loaded-with-allogeneic-tumor-cell-lysate-mesopher-in-subjects-with-mesothelioma-as-maintenance-therapy-after-chemotherapy-dendritic/ 2019-08-12T13:48:37+00:00 monthly 0.2 https://www.mesothelioma-line.com/heterologous-sarcomatoid-pleural-mesothelioma-with-osteosarcomatous-differentiation-a-report-of-autopsy-case-that-accomplished-trimodality-therapy-and-review-of-the-literature/ 2019-08-12T14:00:44+00:00 monthly 0.2 https://www.mesothelioma-line.com/molecular-characterization-of-localized-pleural-mesothelioma/ 2019-08-12T14:41:29+00:00 monthly 0.2 https://www.mesothelioma-line.com/occupational-exposures-to-cosmetic-talc-and-risk-of-mesothelioma-an-updated-pooled-cohort-and-statistical-power-analysis-with-consideration-of-latency-period/ 2019-08-12T14:57:48+00:00 monthly 0.2 https://www.mesothelioma-line.com/an-updated-evaluation-of-potential-health-hazards-associated-with-exposures-to-asbestos-containing-drywall-accessory-products/ 2019-08-12T15:12:02+00:00 monthly 0.2 https://www.mesothelioma-line.com/phase-ii-trial-of-cediranib-in-combination-with-cisplatin-and-pemetrexed-in-chemotherapy-naive-patients-with-unresectable-malignant-pleural-mesothelioma-swog-s0905/ 2019-08-19T14:16:10+00:00 monthly 0.2 https://www.mesothelioma-line.com/chrysotile-fibers-in-tissue-adjacent-to-laryngeal-squamous-cell-carcinoma-in-cases-with-a-history-of-occupational-asbestos-exposure/ 2019-08-19T15:18:06+00:00 monthly 0.2 https://www.mesothelioma-line.com/cumulative-asbestos-exposure-and-mortality-from-asbestos-related-diseases-in-a-pooled-analysis-of-21-asbestos-cement-cohorts-in-italy/ 2019-08-20T13:02:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/exosomal-transfer-of-mir-126-promotes-the-anti-tumour-response-in-malignant-mesothelioma-role-of-mir-126-in-cancer-stroma-communication/ 2019-08-19T16:59:19+00:00 monthly 0.2 https://www.mesothelioma-line.com/dropwort-induced-metabolic-reprogramming-restrains-yap-taz-tead-oncogenic-axis-in-mesothelioma/ 2019-08-19T17:13:43+00:00 monthly 0.2